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ABSTRACT 
 
Gene Expression in the Stallion Testes.  (May 2010) 
Andy Michael Laughlin, B.S., Texas A&M University;  
M.S., Angelo State University 
Co-Chairs of Advisory Committee: Dr. David Forrest 
                                                       Dr. Nancy Ing 
 
 
 Understanding the genes that regulate spermatogenesis and steroidogenesis in 
the testis is critical for enhancement of stallion fertility.  Stallion testicular samples were 
used to identify candidate genes by cDNA microarrays that simultaneously assessed 
expression levels of 9132 genes.  First, gene expression was compared between light 
(spermatogenically active) and dark (spermatogenically inactive) testis tissue of 1.5-
year-old horses (n = 3).  Ninety-three genes were differentially expressed (35 light 
specific, 58 dark specific) in matched paired samples.  Second, gene expression was 
compared between testicular tissue of two mature stallions, one with normal quality 
semen (fertile) and one with poor quality semen (subfertile).  A total of 233 genes were 
differentially expressed (122 in fertile tissue, 111 in subfertile tissue).  Of these, 
phosphodiesterase 3B (PDE3B),  steroidogenic acute regulatory (StAR) protein, and 
outer dense fiber of sperm tails 2 (ODF2) mRNAs, were localized and quantified by in 
situ hybridization (ISH) in mature stallions and/or in unilateral cryptorchids.  ISH 
revealed differences (P < 0.05) among mature stallions (n = 10) for PDE3B (localized to 
seminiferous tubules) and StAR protein (localized to interstitial spaces) mRNAs.  A 
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positive correlation coefficient (r = .556, p = .025) was found between StAR protein 
mRNA and plasma concentration of testosterone.  Additionally, both gene products were 
evaluated in 1-year-old (n = 3) and 3-year-old (n = 3) unilateral cryptorchid stallions.  
Expression of both PDE3B and StAR protein gene was significantly higher in mature, 
descended testes compared to mature, retained testes and the descended and retained 
testes of immature, cryptorchid stallions.  StAR protein gene demonstrated significantly 
higher expression in immature retained testes compared to immature descended testes. 
 A precision-cut tissue slice (PCTS) in vitro culture system was evaluated as a 
potential tool to study equine testes function.  Testes from immature stallions (n = 3) 
were cut into slices (mean slice weight = 13.85 ± 0.20 mg; mean slice thickness = 515.00 
± 2.33 µm) and exposed to medium containing ovine luteinizing hormone (oLH) at 
concentrations of 0, 5, 50 and 500 ng/ml for 6 h at 32°C.  Medium content of 
testosterone and estradiol was increased 500% and 120%, respectively, by addition of 
oLH versus that observed for the testis tissue slices treated with 0 ng oLH (control).  An 
oLH concentration-dependent increase in StAR protein mRNA in tissue slices was 
detected by in situ hybridization; whereas, differences for PDE3B and ODF2 mRNAs 
were not observed.  Collectively, these results demonstrate that the stallion is an 
excellent model for studying male fertility due to the initiation of spermatogenesis, 
frequency of cryptorchidism, and routine castration providing useful tissue to use for 
studying gene expression. 
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CHAPTER I 
INTRODUCTION 
 Identifying the causative mechanisms responsible for male infertility are 
challenging due to the numerous processes that affect gamete production such as 
spermatogenesis and steroidogenesis (Roser, 2008).  Assisted reproductive technologies, 
such as gamete intrafallopian transfer (GIFT) and intracytoplasmic sperm injection 
(ICSI) are valuable assisted reproductive tools available to clinicians and researchers; 
however, they primarily focus on producing offspring from subfertile animals 
(Carnevale, 2008).  Stallions (Equus caballus) are especially prone to fertility problems, 
as evidenced by reports that approximately 38% of all prospective stallions fail a 
breeding soundness examination (Blanchard and Johnson, 1997).  The ability to 
accurately identify aberrant spermatogenic mechanisms that cause reproductive 
inadequacies may increase the number and efficacy of current treatments available to 
clinicians and researchers.  Therefore, a series of experiments were conducted using the 
stallion as a model to provide a better understanding of the specific gene products 
involved in spermatogenesis and useful methods to investigate their functions. 
Ultimately, this research could lead to the development of new strategies to treat and/or 
prevent conditions that cause testicular dysfunction. 
 
 
 
 
 
__________ 
This dissertation follows the style of Journal of Andrology.  
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Objectives 
 This research was designed to identify genes associated with differences in 
spermatogenic capability and semen quality in the stallion testes.  Experiment 1 
consisted of two studies that evaluated genes that were up-/down-regulated in the 
testicular parenchyma of three peripubertal stallions of approximately 1.5 yr of age 
(Study 1A) and two mature stallions >5 yr of age (Study 1B) by microarray analysis.  
Study 1A employed cDNA microarray technology to investigate gene expression 
differences in light (spermatogenically active) and dark (spermatogenically inactive) 
testis parenchyma.  Study 1B also utilized cDNA microarray technology to analyze gene 
expression differences in testicular tissue of two mature horses categorized by either 
high or low semen quality.  The hypothesis of Experiment 1 stated that key genes 
involved in spermatogenesis and/or steroidogenesis are differentially expressed in 
testicular tissues from horses of varying spermatogenic states as a result of: 1) regulation 
by hormones and receptors and/or 2) regulation by paracrine growth factors. 
 Experiment 2 investigated the localization and concentrations of mRNAs 
encoding phosphodiesterase (PDE3B) and steroidogenic acute regulatory protein (StAR) 
genes.  The objective of Experiment 2A was to quantify the level of PDE3B and StAR 
protein mRNA expression in the testis of mature stallions and identify possible 
correlations between hybridization signal strength (mean silver grain densities) and 
fertility parameters such as daily sperm production (DSP), apoptosis rate, daily sperm 
output (DSO), and circulating hormone levels.  We tested the hypothesis that PDE3B 
and StAR protein mRNA hybridization signals are positively correlated with DSP, DSO, 
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and serum testosterone levels in the mature stallions.  Experiment 2B evaluated PDE3B 
and StAR protein mRNA expression levels in retained and descended testes of six 
unilateral cryptorchid stallions (three 1-year-olds and three 3-year-olds).  In these 
immature and mature cryptorchid horses, we hypothesized that mRNA levels for PDE3B 
and StAR protein would differ between the retained and descended testis. 
 The establishment of an in vitro system using whole organ testis slices to study 
testis function and gene regulation was the emphasis of Experiment 3.  The objective 
was to determine if the precision-cut tissue slice in vitro culture system was a viable 
model to investigate testicular function.  The specific aim was to validate the culture 
systems use as a tool for future investigators to evaluate not only endocrine function, but 
also gene expression and regulation in vitro.  In addition, tissue integrity was evaluated 
microscopically.  Viability of cells was evaluated by measuring lactate dehydrogenase 
(LDH) leakage into medium following culture experiments.  Using the precision-cut 
tissue slice in vitro culture system, we evaluated the production and release of steroid 
hormones testosterone and estradiol 17-β (E2) and the expression of PDE3B, StAR 
protein and outer dense fiber of sperm tails 2 (ODF2) genes by the tissues in culture in 
response to stimulation with varying doses of ovine luteinizing hormone (oLH).  We 
tested the hypotheses that the precision-cut tissue slice in vitro culture system may be 
used to demonstrate a dose response in testosterone levels and up-regulation of a 
selected LH-induced gene (StAR protein) following treatments with oLH.  Collectively, 
these experiments contribute new information about spermatogenesis and suggest a new 
technique to study testes function in the stallion. 
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CHAPTER II 
REVIEW OF THE LITERATURE 
Stallion Fertility 
 Stallion infertility can appropriately be defined as the failure to achieve 
fertilization in a mare. This condition can range from temporary subfertility to 
individuals that are permanently sterile.  Identifying the precise cellular mechanisms 
involved in stallions with reduced reproductive potential that fall within this range is 
challenging.  Causes are numerous and can be as simple as poor management practices 
or as obscure as testicular degeneration.  In the equine industry, the most reliable means 
of predicting stallion fertility is the natural breeding of a stallion to large numbers of 
mares and observing the number of offspring born per mating.  However, this practice is 
not routinely performed due to animal costs and time constraints.  It would benefit the 
industry if a more rapid analysis and efficient method could predict a stallion‟s 
reproductive potential. 
 The purpose of this research is to identify testicular genes in the stallion 
associated with normal gamete and/or hormone production.  Clinically, the future goal is 
to identify the cause of reproductive failure and treat the animal efficiently so that the 
full reproductive potential is maximized.  Therefore, two important obstacles must be 
overcome; 1) identification of the etiology responsible for the reproductive disorder and 
2) timely corrective measures to increase fertility in a subfertile animal if possible. 
 In humans, over 60% of male reproductive disorder cases are not identified even 
with the most comprehensive tests and evaluations available (history and physical 
5 
 
examination, hormone profiles, semen analyses, immunological assays, genetic 
screening and studies utilizing ultrasound or Doppler) (Patrizio and Broomfield, 1999). 
It is well known that infertility can affect both males and females alike.  However, the 
results of male infertility in the horse industry are magnified when one stallion has the 
potential to fertilize up to 100 mares in a breeding season by natural service.  According 
to the most recent release in 2005 from the American horse council, horses have an 
annual economic impact on the United States of approximately $39 billion with animal 
numbers reaching over nine million.  Although these numbers represent horses of all 
breeds and ages, many are used for breeding.  Reports indicate that stallions are 
responsible for approximately 65% of low conception rates (Roser, 2001).  Additionally, 
Eisenhauer and Roser (1995) imply a trend towards an increase in subfertility in stallions 
at breeding facilities.  Exact clinical diagnosis of animals with reduced fertility is 
difficult.  Limited therapeutic tools compound the problem often leading to ineffective 
treatments (Douglas and Umphenour, 1992; Ball, 2008).  Identifying the underlying 
causes of infertility with advances in technology would benefit the welfare of the horse 
industry.  Although interest in stallion fertility has increased over the past years, more 
research in the area of molecular diagnostics is necessary to enhance the current 
therapeutic strategies, such as intracytoplasmic sperm injection (ICSI), for infertile and 
subfertile horses (Carnevale, 2008). 
Stallion Reproductive Anatomy and Function 
 The reproductive system of the stallion encompasses the testes, epididymis, 
ductus deferens, accessory sex glands and penis.  Collectively, these structures produce 
6 
 
and transport spermatozoa and seminal fluid (the ejaculate) to the female.  The 
anatomical development and maturation of these tissues are essential functions and 
attainment of reproductive capability is dependent upon each. 
Testes 
 The testes synthesize and secrete hormones as well as produce the male gametes.  
The testis of the stallion is covered by two connective tissue layers, the tunica albuginea 
and the visceral vaginal tunic, collectively termed the testicular capsule (Senger, 2003).  
Histologically, a cross section through a testis reveals the parenchyma which is divided 
into an interstitial compartment and a tubular compartment.  The major components of 
the interstitial compartment are Leydig cells, which produce testosterone, peri-tubular 
cells, and the vascular supply.  The tubular compartment is made up of the seminiferous 
tubules.  Located within the seminiferous tubules are the developing germ cells 
(spermatogonia, spermatocytes, spermatids) and the somatic Sertoli and myoid cells 
(Johnson et al, 1997). 
 Spermatozoa are continually produced in post-pubertal animals with normal 
testicular development.  However, testicular size and activity peaks during the natural 
breeding season as opposed to the non-breeding season (summer, natural breeding 
season; winter, nonbreeding season).  Variations in testicular cell populations and weight 
have been well documented in stallions due to age and season (Johnson and Neaves, 
1981; Johnson and Thompson, 1983; Johnson and Thompson, 1986).  As stallions age, 
the testicular weight, number of Leydig cells and Leydig cell population per ml of testis 
volume all increase.  In addition, day length affects the daily sperm production (DSP) of 
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stallions (Johnson et al, 2000b).  Seasonal differences in stallions have shown that paired 
testicular weights in grams, total number of Leydig cells per testis and Sertoli cell 
numbers were higher in the breeding season compared to the nonbreeding season 
(Johnson and Thompson, 1986). 
Epididymis and ductus deferens 
 The epididymis is a highly convoluted duct attached to each testis and functions 
as a spermatozoa storage and maturation organ.  Three anatomical regions are 
recognized in the epididymis; the caput (head), the corpus (body) and the cauda (tail).  
Spermatozoa and rete fluid exiting the testis enter the caput epididymis via the efferent 
ducts.  In the stallion spermatozoa are retained in the caput for approximately one day 
where rete fluid is reabsorbed (Senger, 2003).  Motility and fertility of spermatozoa 
begin to be evident as spermatozoa move into the corpus and reside for approximately 
two days eventually reaching full motility and fertility in the cauda.  Stallion 
spermatozoa are stored in the cauda of the epididymis and can maintain the ability to 
fertilize an oocyte for several weeks.  Spermatozoa stored in the cauda epididymis are 
transported by smooth muscle contractions of the ductus deferens to the ampulla which 
leads to the pelvic urethra (Senger, 2003).  The urethra is defined as the tube beginning 
at the bladder and terminates at the glans penis.  Both urine and semen (spermatozoa 
with contributions from the accessory sex glands) exit the stallion through the urethra. 
Accessory sex glands 
 Secretions from the accessory glands (as well as some from the epididymis) 
provide fluid for spermatozoal transport and constitute the seminal plasma.  
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Additionally, these secretions provide nutrition and buffers to alleviate hostile acidic 
conditions found in the female reproductive tract.  These contributing glands in the 
stallion include the vesicular glands, prostate and bulbourethral glands.  Limited 
information is known about the complete function of each accessory gland in the stallion 
and is beyond the scope of this research. 
Penis 
 The penis is the copulatory organ.  The anatomy of the stallion penis is 
characterized as vascular.  Upon sexual stimulation the spongy tissue is filled with blood 
increasing both the length and diameter of the penis. On the distal end of the penis is the 
bell-shaped glans.  The glans region is highly innervated and is responsible for inducing 
the ejaculatory process (Senger, 2003).  During natural breeding the glans of the stallion 
penis engorges with blood (a condition called belling) and is anatomically positioned 
during copulation to be adjacent to the mare‟s cervical canal so that semen is deposited 
directly into the uterus. 
Endocrinology of Male Reproduction 
 Hormones synthesized and secreted by the hypothalamus, anterior pituitary and 
testes, known as the hypothalamic-pituitary-testicular axis (HPT), control male 
reproductive functions (Roser, 2008).  These hormones establish and support germ cell 
production and regulate the sexual characteristics of males (Matsumoto, 1989).  
Although steroidal androgens are considered the dominant male hormones, reproductive 
hormones are not limited to these plasma membrane diffusible molecules.  Protein 
hormones such as gonadotropin releasing hormone (GnRH), luteinizing hormone (LH), 
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follicle stimulating hormone (FSH), and inhibin bind to receptors located on plasma 
membranes and are actively involved in male reproduction.  Modulation of the HPT on 
the release of GnRH and the gonadotropins is controlled by feedback loops from 
hormones such as testosterone, estrogen, and inhibin, which are produced by the testes. 
 The hypothalamus is responsible for the synthesis and secretion of the 
decapeptide, GnRH.  In the stallion, GnRH is secreted in a pulsatile manner and it 
regulates the episodic release of LH and FSH from the anterior pituitary (Irvine and 
Alexander, 1987).  Protein hormones are unable to freely diffuse through the external 
phospholipid bilayer of cells and; therefore, act through second messenger systems.  
Luteinizing hormone modulates the secretion of testosterone.  In the human, it has been 
established that FSH binds to receptors located on Sertoli cells and causes the release of 
protein hormones such as inhibin, activin and androgen binding protein (ABP) 
(Matsumoto, 1989).  Similar actions of FSH binding to receptors on Sertoli cells are 
thought to occur in stallions; however, this has not been proven (Roser, 2001). 
Testosterone 
 Androgens, such as testosterone, are steroid derivatives of cholesterol 
metabolism.  Testosterone is a 19 carbon steroid molecule produced by the interstitial 
cells of Leydig (Senger, 2003).  Testosterone has numerous functions and is essential for 
maintaining and restoring spermatogenesis in adults, affecting sexual drive (libido), 
stimulating metabolism, initiating and sustaining male secondary sex characteristics, and 
supporting organs of the male reproductive tract (Roser, 2001; Martini, 2006).  Once 
secreted, testosterone can either be converted to dihydrotestosterone (DHT), be 
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aromatized to estradiol, it can suppress GnRH release from the hypothalamus by 
negative feedback, and it can influence growth of tissues (Senger, 2003).  Circulating 
concentrations of androgens in stallions vary due to season and age.  Most reports 
indicate that mature, fertile stallions (> four-years-old) have circulating testosterone 
levels that are approximately 0.5 ng/ml in the nonbreeding season and can rise to 
approximately 2.0 ng/ml during the breeding season (Johnson and Thompson, 1983; 
Roser and Hughes, 1992a; Roser and Hughes, 1992b, Inoue et al, 1993; Clemmons et al, 
1995; Nagata et al, 1998).  In addition, it has been shown that DHT follows the same 
pattern as testosterone, but at lower concentrations, where the ratio of testosterone: 
dihydrotestosterone was reported at a 6:1 (Bono et al, 1982). 
 Steinberger (1971) demonstrated that long term administration of low levels of 
testosterone systemically inhibits the completion of spermatogenesis.  Incomplete 
spermatogenesis due to severely low levels of testosterone in mice was also reported 
where histological analysis of testis showed meiotic cells and round spermatids, but not 
elongated spermatids (Kumar, 2005).  Studies have also indicated that the direction of 
action and target of testosterone can augment spermatogenesis in normal mice but 
suppresses spermatogenesis in juvenile spermatogonial depleted (jsd) mice (Meistrich 
and Shetty, 2003).  This negative effect of androgens on FSH and LH secretion 
reportedly occurs at the level of the hypothalamus (Tilbrook, 1991; Muyan et al, 1993). 
Follicle stimulating hormone 
 The glycoprotein, FSH, stimulates spermatogenesis by binding to receptors 
located on Sertoli cells.  Therapeutically, FSH has been used in the treatment of 
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infertility, especially in cases where sperm dysfunction has been diagnosed and in vitro 
fertilization (IVF) or intracytoplasmic sperm injection (ICSI) has been used (Rose et al, 
2000).  Stimulation of spermatogenesis with FSH has also been used in individuals with 
azoospermia due to hypogonadotrophic hypogonadism or pituitary failure. 
 In the stallion, FSH appears more critical during puberty and may not be as 
significant in adults as previously thought.  Circulating levels of FSH in post-pubertal 
stallions are approximately 6 ng/ml in the breeding season and decline to approximately 
4 ng/ml in the non-breeding season (Roser and Hughes, 1992b; Nagata et al, 1998).  
Roser (2001) reported that in vitro culture of testicular tissue from stallions five years of 
age and older treated with equine FSH showed no effect on steroidogenesis (production 
and release of T and E2); however, when treated with 50 ng/ml of equine LH, an 
increased production of these hormones was observed.  In transgenic mice, FSH is not 
essential for male fertility. However, spermatogenesis is hampered and results in 
abnormally low sperm output (Kumar et al., 1997).  One documented difference between 
the synergistic roles of testosterone and FSH reported by Zirkin et al. (1994) is that 
testosterone affects sperm production qualitatively and FSH influences quantity. 
Luteinizing hormone 
 Luteinizing hormone is essential for male fertility.  It functions in binding to LH 
receptors on Leydig cells and subsequently causes testosterone release.  Knockout male 
mice for the LH ligand are infertile and show a significant decrease in testes size, 
accessory gland size, intra-testicular testosterone level and Leydig cell number (Kumar, 
2005).  Interestingly, FSH levels are not affected in LH knockout mice compared to 
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normal controls.  Quantification of basal levels of LH in stallions documented in the 
literature is highly variable due to differences in timing and techniques used to obtain 
and measure samples.  Johnson and Thompson (1983) demonstrate that as age increases 
in the stallion, circulating concentrations of LH and FSH increase.  They also report that 
these hormones are elevated in the breeding season compared to the nonbreeding season.  
Luteinizing hormone levels increase on the order of three times more in the breeding 
season (approximately 6 ng/ml) compared to the non-breeding season (approximately 2 
ng/ml) (Roser and Hughes, 1992a; Nagata et al, 1998).  Eisenhauer and Roser (1995) 
reported that stallion testicular tissue treated with 5 ng/ml of equine LH increased 
testosterone levels in a stallion in vitro system 30 fold over basal levels. 
Estrogen 
 The presence of estrogenic compounds in stallions has been known for a long 
time (Zondek, 1934). However, a function was not discovered until the 1990‟s when the 
estrogen receptor knockout (αERKO) mouse was generated (Lubahn et al, 1993).  The 
αERKO model demonstrated that the estrogen receptor and; therefore, estrogen is 
necessary for male fertility.  Hess (2003) reviews how estrogens are metabolized from 
androgens through the P450 aromatase enzyme in a process termed aromatization. 
 In the stallion large amounts of estrogens are produced by the testes which make 
them unique to other males (Raeside, 1969; Eisenhauer and Roser, 1995).  The major 
estrogenic compound produced in the stallion is estrone sulfate (E1), a conjugated steroid 
(Raeside, 1969).  Circulating levels of E1 in the stallion fluctuate throughout the season 
and can range from approximately 100-200 pg/ml (Thompson et al, 1978; Bono et al, 
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1982; Roser and Hughes, 1992a). Additionally, estradiol 17-β (E2) is found in high 
concentration and circulating levels in the stallion have been reported at approximately 
150 pg/ml and 50 pg/ml for the breeding and non-breeding season, respectively 
(Thompson et al, 1978; Nagata et al, 1998).  An important function of E2 is regulation of 
fluid dynamics in the male tract (Hess, 2003).  Estradiol 17-β in the stallion has also 
been shown to have an agonistic affect on the release of GnRH-induced LH secretion 
from the pituitary gland (Muyan et al, 1993).  Its affect on FSH is thought to be 
antagonistic since treatments with estradiol or testosterone decreased circulating levels 
(Thompson et al, 1979). 
Spermatogenesis 
 Spermatogenesis has been defined as the collection of events in the testes that 
relies on endocrine, paracrine and autocrine regulatory mechanisms to produce 
spermatozoa (Weinbauer and Wessels, 1999; Johnson et al, 2000).  A review of 
spermatogenesis in the stallion by Johnson et al, (1997) describes the cell types, stages 
and the changes that take place in the seminiferous tubules which enables the production 
of spermatozoa from immature germ cells.  Briefly, spermatogenesis is categorized into 
three phases; spermatocytogenesis, meiosis and spermiogenesis.  During 
spermatocytogenesis, the most immature germ cells (spermatogonia) develop.  They are 
populated on the basement membrane of the seminiferous tubules.  There are five 
subtypes of spermatogonia known as A1, A2, A3, B1, and B2 in the stallion (Johnson et 
al, 1997).  These cells grow, differentiate and divide by mitosis until ultimately the B1 
spermatogonia divide producing preleptotene primary spermatocytes.  Spermatocytes are 
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capable of undergoing meiosis; therefore, the meiotic phase includes the genetic 
recombination activity (crossing over) and concludes with the production of haploid 
spermatids.  After the second meiotic division, these cells develop into haploid round 
spermatids.  The final phase is the non-dividing period of spermiogenesis, where round 
spermatids elongate into spermatozoa.  Heninger et al, (2004) describes these cells based 
on the eight stages of the equine seminiferous epithelium.  This developmental process 
provides a potential for interruption in the production of viable spermatozoa, and 
subsequently can cause subfertility or infertility.  Intense investigation in the area of 
spermatogenesis has led to an appreciable understanding of its complex components 
such as proliferation, meiosis, and differentiation.  However, the genetic factors critical 
for the continuous process of spermatogenesis have remained elusive. 
 Models used to investigate spermatogenic events have included humans, rodents, 
pigs, and stallions (Peterson and Russell, 1985; Jones and Berndtson, 1986; Wolgemuth 
et al, 1995). Utilization of the stallion provides a useful model to investigate 
spermatogenesis.  Specifically, the unique spatial initiation of spermatogenesis at 
puberty, opportunity for frequent testis sample collection by the common management 
practice of routine castration, and testis size make the stallion an excellent model system. 
Initiation of Spermatogenesis in the Stallion 
 In most mammals, initiation of spermatogenesis occurs at random sites 
throughout the testis (Clemmons et al, 1995).  However, in the stallion, this process 
begins at the onset of puberty in the central region of the testis and progressively 
migrates peripherally (Clemmons et al, 1995).  Testicular parenchyma of pre-pubertal 
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animals is dark, reddish-brown in color due to small, closed seminiferous tubules.  These 
seminiferous tubules are incapable of producing mature germ cells and are 
spermatogenically inactive (Clemmons et al, 1995).  At approximately 1.5 yr of age, the 
stallion reaches puberty and spermatogenesis begins in the central region of the testis 
proximal to the central vein.  Spermatogenically inactive equine testicular tissue can be 
differentiated from spermatogenically active tissue by visual observation of a gross 
change in color from dark, reddish-brown to a light parenchymal color.  The observed 
shift in tissue structure and color is due to the formation of larger tubules as well as 
spatial changes in Leydig cells, which ultimately results in spermatogenic activity 
(Clemmons et al, 1995).  This system provides an excellent model to study 
spermatogenesis wherein, both spermatogenically inactive (dark) and active (light) tissue 
can be evaluated in the same animal under the same environmental conditions and same 
hormonal milieu.  Currently, there are no other known livestock species that exhibit 
similar physiological changes within the testis. 
Cryptorchidism 
 Embryonic testicular development occurs in the abdomen.  However, for normal 
spermatogenesis to proceed in mammals, a hypothermic environment compared to 
normal body temperature is essential for gamete production.  Testicular cooling is 
initiated by descent into the scrotum where scrotal temperature is lower than the 
temperature in the body cavity.  In the horse, core body temperature is approximately 
38°C and scrotal temperature is approximately 32°C (Green et al, 2005; Staempfli et al, 
2006).  In the colt, descent through the inguinal ring occurs between 300 days of 
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gestation and 10 days after birth (Bergin et al, 1970).  Occasionally, one or both testes 
fail to completely descend into the scrotum.  This condition is termed unilateral or 
bilateral cryptorchidism, respectively, and occurs in several species. However, it is most 
frequent in the equine and porcine species (Bergin et al, 1970). 
 In humans, cryptorchidism is considered to be the most frequent reproductive 
disturbance in newborns that requires surgical and medical assistance (Bilinska et al, 
2003).  This condition has been used as a model to study spermatogenic and 
steroidogenic functions in several species such as mice (Meistrich et al, 1973), rats 
(Shakeel et al, 2001), bulls (Volger et al, 1991), rams (Mieusset et al, 1991), boars 
(Raeside et al, 1988) and stallions (Blanchard et al, 2000).  In stallions and humans, 
previous studies have demonstrated that cryptorchidism is associated with reduced 
fertility through elevated testicular temperatures incompatible with spermatogenesis 
(Cox and Williams, 1975; Stickle and Fessler, 1978; Hayes, 1986; Hejmej and Bilinska, 
2008).  Arighi et al, (1987) compared stallions with normal scrotal descent of testes to 
those with inguinal and abdominally retained testes and showed that mean weight, size, 
layers of germs cells present and tubular diameter were all increased in scrotal testes.  
Histological evidence revealed full spermatogenic development in the scrotal testes; 
however, development was arrested in early spermatocytes in tissue retained in or at the 
inguinal canal.  Testes retained in the abdominal cavity had no germ cell development 
past spermatogonia.  One report states that elevated abdominal temperature does not 
decrease hormone synthesis since Leydig cell numbers are increased in abdominal 
compared to scrotal testes (Araghi et al, 1987).  This increase, not only in interstitial 
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cells but in the amount of interstitial space as well, resulted in higher circulating 
concentrations of estrone sulfate and testosterone in these stallions.  Others report that 
when stallion testicular temperatures were experimentally elevated by insulating the 
testes, semen quality, sperm motility, concentration and number of ejaculates decreased 
(Blanchard et al, 2000). In the same study, circulating testosterone levels decreased and 
LH levels increased after removal of thermal insult.  Although the morphological 
changes in cryptorchids are well established, the cellular and molecular changes causing 
testicular degeneration is not fully understood. 
Methodologies for Evaluating Fertility in Stallions 
 The limited number of tests available to clinically assess fertility in stallions has 
stimulated a demand for researchers to investigate additional methodologies.  One of the 
roles of research is to create and/or validate procedures that can be added to the current 
repertoire of tests for clinicians.  Clinically, the most desirable and definitive test for 
evaluating a stallion‟s fertility is through breeding trials where an individual stallion is 
bred to a cohort of mares and conception rate and/or live birth percentages are 
determined.  However, this may not be economically feasible to clientele. 
 The most commonly evaluated diagnostic methods used clinically are physical 
examinations of the reproductive system and ejaculate assessments for sperm motility, 
sperm number, and sperm morphology because these are non-invasive procedures and 
are quick (Ball 2008).  In addition, some veterinarians are incorporating multiple tests 
along with the previously mentioned common assessments such as ultrasonography and 
the utilization of endoscopy of the urethra to evaluate lesions and/or infections of the 
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accessory sex glands (Ball 2008; Varner 2008).  General methods used to evaluate 
stallion semen include total motility which is an estimation of the percentage of 
spermatozoa that demonstrate movement and progressively motile spermatozoa (PMS) 
which indicate only those cells that are actively moving forward or in a path with 
circular motion (Ball 2008; Varner et al, 2008).  Other general methods used to evaluate 
fertility are sperm concentration, DSO, sperm morphology, and the sperm chromatin 
structure assay (SCSA) (Johnson et al, 2000; Thompson et al, 2004; Love 2005).  Sperm 
concentration is most often determined by counting cells with the aid of a 
hemocytometer, or by photometric or fluorescence analysis (Varner et al, 2008).  DSO 
can be measured as actual or predicted daily sperm output.  The actual DSO is 
determined by multiple daily semen collections (minimum of seven consecutive days) 
and the reported value is the mean of the final three days of semen collections.  Predicted 
DSO is determined by measuring testicular dimensions by ultrasound and calculating 
values using prediction equations (Varner et al, 2008).  It has been estimated that in 
sexually mature stallions the DSO is around five billion spermatozoa per day; however, 
season and age can cause this number to fluctuate (Thompson et al, 2004).  Hormone 
profiles for T, E2, FSH, LH and inhibin are assessed clinically and are critical in 
understanding fertility.  Although reports in the literature of basal hormone 
concentrations in stallions are inconsistent, the variation is mostly attributed to 
radioimmunoassay methods across different laboratories (Thompson et al, 1979; Irvine 
and Alexander, 1987; Stewart and Roser, 1998).  In addition, these hormone levels vary 
among horses of different ages and samples collected during different seasons.  A recent 
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tool that has become available to clinical practitioners is the sperm chromatin structure 
assay (SCSA).  SCSA enables the evaluator to assess DNA damage in sperm cells based 
on the amount of dye incorporated into single stranded DNA (ssDNA) or double 
stranded (dsDNA).  Reports in some species have indicated that sperm cells with high 
concentrations of fragmented DNA (ssDNA as opposed to dsDNA) are related to 
subfertility (Love, 2005). The limitation to frequent use of SCSA is the need for a flow 
cytometer in the laboratory. 
 Techniques utilized in research for the purpose of evaluating infertility include 
the assessment of DSP and apoptotic rate.  These tests are more invasive, can require 
whole testis samples, and may cause irreversible damage to the testicular tissue.  
Additionally, these procedures are often labor intensive and the results from tests may 
not be available for several days.  However, research methodologies utilized to 
investigate infertility are valuable tools as they provide insight into the mechanisms that 
regulate testicular function.  Daily sperm production is a calculation of the number of 
spermatozoa produced by both gonads in a day and is a good predictor of testicular 
function.  However, DSP is an invasive technique commonly assessed by estimating the 
number of mature spermatid nuclei seen by phase-contrast cytometry after 
homogenization of testicular tissue (Amann et al, 1976; Johnson and Neaves, 1981).  
Johnson and colleagues (2000) characterized daily sperm production per gram of 
parenchyma at different developing stages of spermatogenesis for several species.  The 
rate of germ cell death and specific hormone levels can also be used as a diagnostic tool 
for understanding fertility.  Apoptosis, or programmed cell death, is the intentional 
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removal of cells from specific tissues.  This ATP requiring mechanism has been well 
documented in the testis and in several species including the stallion (Santos et al, 1999; 
Lue et al, 2002; Heninger et al, 2004).  In cases where testicular degeneration is a 
concern, research options like apoptosis studies, tissue biopsies, microarrays, in situ 
hybridization studies, and tissue culture can evaluate aberrant functions in the testis.  
One example is the work by Heninger and colleagues (2004) that demonstrated 
significantly higher rates of apoptosis in stage IV and V stallion seminiferous tubules.  
However, the procedures used to determine these valuable results required whole testis 
samples of normal stallions which would not be used in clinical diagnosis.  It does; 
however, contribute greatly to our knowledge of how spermatogenesis occurs.  
Microarrays 
Advancements in biotechnology have provided numerous methods for the 
detection and quantification of gene expression.  Until recently, gene expression studies 
evaluated differences between two or more cells at varying time intervals, treatment 
conditions or in different tissues using traditional methods such as northern blots, 
differential display-reverse transcription polymerase chain reaction and sequencing of 
cDNA libraries (Kamberova and Shah, 2002).  However, the vast amount of information 
provided by complete sequencing of genomes has demanded a better solution to 
evaluating larger numbers of gene products more efficiently.  One tool that enables 
researchers to investigate a large number of gene products that are up- and down-
regulated within a system is the microarray.  It has been rapidly utilized in the fields of 
biological and medical sciences as well as in the pharmaceutical industry (Rockett et al, 
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2001a).  Other names include DNA arrays, complementary DNA (cDNA) arrays, and 
genome chips (Rockett and Dix, 1999).  Prior to the introduction of microarray 
technology the conventional experiments available were time consuming and severely 
limited the number of genes to be investigated in a single experiment.  Microarray 
technology overcame this obstacle which allowed for high through-put screening of 
thousands of gene products simultaneously in one experiment (Schena et al, 1995). 
Microarrays are ordered spots of DNA probes attached to solid surfaces such as 
glass slides or nylon (Kamberova and Shah, 2002).  The DNA molecules can either be 
oligonucleotides (short sequences ranging from 20 to 60 base pairs in length) or cDNAs, 
which are typically much longer and allow for more specificity.  Oligonucleotides, or 
cDNAs, correspond to a specific gene sequence and are spotted and attached to the 
surface of slides.  A microarray experiment first begins by isolating mRNA from test 
samples and labeling each with a different fluorescent dye.  The samples are allowed to 
hybridize in parallel to DNA sequences immobilized onto a solid surface (Schulze and 
Downward, 2001).  Transcripts can then be simultaneously detected and quantified by 
fluorescent scanning instrumentation by measuring the amounts of specific fluorescence 
at each coordinate. 
 Microarray technology has become a popular tool in analyzing spermatogenic 
function and regulation based on the number of investigators using array methodology 
(Rockett et al, 2001b; Tanaka et al, 2002; Sha et al, 2002; Ohta and Fuse, 2002; Schultz 
et al, 2003; Pang et al, 2003; Yu et al, 2003; Almstrup et al, 2004; Hoffer et al, 2005).  
Employment of arrays has opened the field to greater knowledge of multiple gene 
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interactions and timing of events during the developmental processes of maturing male 
germ cells. Canadian researchers isolated three different spermatogenic cells 
(spermatocytes, round spermatids and elongated spermatids) of adult Sprague-Dawley 
rats and found that of 216 gene probes on the commercial array used, 96 were expressed 
in those cells (Aguilar-Mahecha et al, 2001).  Additionally, only 50% of the expressed 
genes were found in all three cell types evaluated and only 25% were detected in both 
spermatocytes and round spermatids.  This leads to the observation that there must be 
specific genes under transcriptional and translational control that dictate germ cell 
maturation in the testis.  Others have used microarrays to identify specific cells in the 
testes that are hormonally regulated (McLean et al, 2002) or to determine which genes 
are over expressed or under expressed in two different testicular germ cell tumors 
(Hoffer et al, 2005). 
 Commercial microarrays have been available for multiple species such as 
humans and rodents since 2000 (Rockett et al, 2001a; Sha et al, 2002).  Recently, equine 
specific microarrays have been added to this list which are available to the public (see 
reviews, Chowdhary and Raudsepp, 2008; Ramery et al, 2009).  Prior to the availability 
of equine specific microarrays, in order to use microarray technology to investigate gene 
expression in equine tissues, cross-species hybridization using long cDNA microarrays 
was utilized (Ing et al, 2004).  Cross-species hybridization has proven valid in cDNA 
microarray experiments where porcine RNA was hybridized to human nylon 
microarrays (Moody et al, 2002).  Using this methodology, we hybridized both dark and 
light testicular parenchyma of peri-pubertal stallions and tissue from two mature 
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stallions that differed in semen quality parameters to human cDNA targets (Ing et al, 
2004).  These experiments identified important transcripts that were up- or down-
regulated in the different tissue and narrowed the focus on key regulators involved in 
spermatogenic function. 
Genes of Interest 
 Although many genes have been implicated in pathways resulting in normal and 
abnormal testicular function, this project involved evaluating the gene expression of 
three transcripts in the male testes; PDE3B, StAR protein and ODF2.  All three were 
found to be differentially expressed on at least one of the microarrays conducted in these 
experiments.  In addition, StAR protein and ODF2 mRNA have previously been 
identified in other reported testes specific microarray results thereby validating their 
importance in male reproduction (Aguilar-Mahecha et al, 2001; Sha et al, 2002; McLean 
et al, 2002).  To our knowledge, PDE3B specifically has not been previously reported in 
other testes specific microarrays, although several phosphodiesterase family members 
have.  
Phosphodiesterase 
 An important pathway responsible for eliciting a cellular response involves 
signal transduction by intracellular second messengers such as cyclic 3‟, 5‟- 
monophosphate (cAMP) and cyclic 3‟, 5‟- guanosine monophosphate (cGMP) (Conti, 
2000).  Theses second messengers are tightly regulated through the synthesis of adenylyl 
and guanylyl cyclases, via activation through hormone interactions with membrane 
bound G protein coupled receptors, and by the rate of hydrolysis through PDEs (Fawcett 
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et al, 2000).  Cyclic nucleotide phosphodiesterases are enzymes that hydrolyze cyclic 
nucleotides, thereby, terminating their downstream activities and have been implicated 
in negative feedback mechanisms that control these second messengers (Park et al, 
2002). 
 The PDE enzymes are structurally related; however, they differ in sequence, 
chemical properties, inhibitor responses, regulatory mechanisms, and cellular 
localization (Miki et al, 1996).  Currently, eleven families (PDE1-11) have been 
identified and are classified into five groups according to their substrate affinities, which 
include cAMP-specific, cGMP-specific, Ca2+/calmodulin-stimulated, cGMP stimulated, 
and cGMP inhibited PDEs (Welch et al, 1992).  All PDEs to date have a conserved ~270 
amino acid sequence in the catalytic domain of the enzyme and differ in their N-terminal 
domains (Beavo, 1995). 
 One particular family, the type III PDE isoenzymes also known as cyclic GMP-
inhibited PDEs, is unique in that those PDEs hydrolyze both cGMP and cAMP.  
However, the hydrolysis of cAMP is inhibited by low concentrations of cGMP, 
speculated to be caused by competitive binding.  Specific to this family is a 44 amino 
acid insert in their conserved domains, which does not align with other PDEs, and are 
designated as PDE3A and PDE3B (Miki et al, 1996).  The two members of the PDE3 
family are unique in their binding ability for both cAMP and cGMP; however, the Vmax 
for cGMP is lower than that of cAMP (Manganiello et al, 1995).  Although PDE3A and 
PDE3B are similar, they are distinct genes that map to different chromosomes.  PDE3A 
maps to human chromosome 12 and equine chromosome 6; whereas, PDE3B maps to 
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human chromosome 11 and equine chromosome 7 (Miki et al, 1996).  Gene expression 
studies of PDE3A and PDE3B have shown that these two isoforms are found in different 
tissues in the body.  PDE3A has been found in the cardiovascular system, smooth 
muscle cells of the gastrointestinal tract, and oocytes.  PDE3B is highly expressed in 
adipose tissues, hepatocytes, renal epithelium, and in the cells of the seminiferous 
tubules (Reinhardt et al, 1995). 
The members of the PDE3 family are activated through phosphorylation by 
products that increase intracellular cAMP concentrations, such as forskolin, and are 
specifically sensitive to inhibitors such as milrinone and cilostamide (Miki et al, 1996; 
Conti, 2000).  The majority of our understanding of PDE3B has been through its link to 
the insulin pathway, whereby, phosphorylation of the enzyme regulates the effects of 
insulin on lipid metabolism.  One theory suggests that low levels of PDE3B in patients 
with diabetes cause an increase in lipolysis and acidosis (Beavo, 1995; Zhao et al, 1997; 
Harndahl et al, 2002). 
 Butcher and Sutherland (1962) were the first to describe cAMP.  Included in 
their discussion was the discovery of specific enzymes reported to degrade cAMP.  
These enzymes were later identified as phosphodiesterases.  In this discussion, it was 
suggested that hormones might control the rate of cyclic nucleotide degradation.  Based 
on these findings, investigators began to examine the link between PDEs and their role 
in the reproductive system.  One of the preliminary studies of PDE involvement in 
reproduction was conducted in Drosophila melanogaster.  In this study, investigators 
reported that in flies, mutations encoding the PDE gene at the dunce locus resulted in 
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female sterility (Saltz and Kiger, 1982).  Later studies demonstrated that FSH in rats 
caused not only an increase in adenylyl cyclase leading to an increase in cAMP, but also 
stimulated an increase in production of PDE activity as well (Conti et al, 1983).  More 
recently, knockout mice for PDE3A, PDE3B and PDE4D have been generated.  
Interestingly, PDE3A knockout female mice are sterile due to the lack of cAMP 
hydrolysis.  In this study, oocytes were arrested in prophase I of the first meiotic division 
and could not resume maturation due to the elevated cAMP levels (Wiersma et al, 1998; 
Masciarelli et al, 2004).  PDE4D null mice also display an obvious phenotype that 
results in smaller bodied mice and females exhibit a 75% reduction in ovulation rate and 
reduced fertility (Jin et al, 1999).  Interestingly, PDE3B knockout mice are fertile but 
demonstrate reduced gonadal adipose tissue and are overall leaner than wild-type mice 
indicating that PDE3B may be involved in energy metabolism (Choi et al, 2006).  To 
date, the overall effects of PDE3B on spermatogenesis have not been investigated in 
PDE3B knockouts.  These studies indicate the importance of PDEs in mice 
gametogenesis. 
 Although most of the progress on PDE function in reproduction has been learned 
through studies in the female, important implications have been realized in the male that 
contribute to the need for further investigation.  Dibutyryl-cAMP, a cAMP analog, was 
first shown to inhibit mitosis in vivo at the level of the testis when given to rats 
(Hollinger and Wang, 1974).  This study implied that there is a necessary mechanism for 
decreasing cAMP levels for appropriate germ cell maturation, and suggested that one of 
the PDEs was involved in this pathway.  Later, Verhoeven and colleagues attempted to 
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show that FSH decreased PDE activity; however, their hypothesis was proven incorrect 
when they reported that FSH and isoproterenol stimulated PDE activity in cultured rat 
Sertoli cells (Verhoeven et al, 1981).  At this time, it was realized that several forms of 
PDE were present in the testis, and there were different concentrations of PDEs that 
were dependent upon germ cell development.  Subsequent studies using immature rats 
demonstrated that FSH increased PDE levels in the seminiferous tubules but not in the 
interstitial space (Conti et al, 1983).  In order to show that different PDEs act in the 
testis, Yan and colleagues (2001) evaluated the expression of PDE1A, PDE1B, and 
PDE1C genes.  Results of their investigation showed that PDE1A mRNA was found in 
round to elongated spermatids, PDE1C mRNA was found in stages with germ cells 
undergoing meiotic divisions, and PDE1B mRNA was found in both the seminiferous 
epithelium and the interstitial space of the testis. 
 Of the eleven PDE family members, eight have been localized to the testis by in 
situ hybridization and include varying isoforms of the PDE1, PDE2, PDE3, PDE4, 
PDE7, PDE8, PDE10, and PDE11 families (Morena et al, 1995; Soderling et al, 1999; 
Soderling and Beavo, 2000; Sasaki et al, 2002).  Based on previous research and 
localization of the PDE3B gene, we expected to find it more abundantly expressed in 
testis tissue that is actively involved in spermatogenesis.  Further investigation of this 
particular enzyme function in the testis will be beneficial for unmasking its regulatory 
role in spermatogenesis. 
Steroidogenic acute regulatory protein (StAR) 
 In contrast to PDEs, the role of StAR protein in the testis has been well 
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characterized.  The rate-limiting step in steroid synthesis occurs in the mitochondria 
where cytochrome P450 cholesterol side-chain cleavage enzyme complex (P450ssc) 
converts cholesterol to pregnenolone (Miller, 1988; Clark et al, 1994; Stocco and Clark, 
1996).  P450ssc resides on the inner mitochondrial membrane and requires cholesterol to 
be transported from the outer to the inner membrane to initiate steroidogenesis (Kerban 
et al, 1999).  Cholesterol delivery to the inner mitochondrial membrane is accomplished 
by StAR protein.  It has been confirmed as the translocating enzyme through knockout 
mice and cell culture studies (Sugawara et al, 1995; Caron et al, 1997).  Arguably, the 
most important work demonstrating that StAR is crucial for steroidogenesis is the human 
condition lipoid congenital adrenal hyperplasia.  This condition results from a mutation 
in the StAR gene causing a defect in the cholesterol transporting ability of the enzyme.  
Individuals with this autosomal recessive, potentially lethal disorder are unable to 
produce steroids and often have large accumulations of cholesterol in the body (Reyland 
et al, 2000).  Knockout mice for StAR protein show similar traits to the human condition 
with substantial lipid deposition in the adrenal gland and a reduction in corticosterone 
production (Manna and Stocco, 2005). 
 StAR protein gene transcripts have been localized in tissues that synthesize 
steroids such as the adrenal glands, ovary, brain, placenta, and testis (Pollack et al, 1997; 
Manna and Stocco, 2005).  The StAR gene is induced by LH through a second 
messenger pathway.  Gene expression studies have demonstrated increased mRNA 
levels within 30 minutes after stimulation with human chorionic gonadotropin (hCG) 
with continual increase for 6 hr (Manna et al, 2004).  Currently, the gene encoding StAR 
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protein has been of interest for patients with Alzheimer disease (AD).  Investigators 
report that patients with AD have an increased level of StAR protein and LH receptor 
expression in specific neuronal regions of the brain compared to controls (Webber et al, 
2006).  Our studies are expected to demonstrate a decrease in StAR protein gene 
expression levels in horses with reduced fertility parameters. 
Outer dense fiber of sperm tails 2 
 In mammalian species, sperm motility is controlled by the flagellum and a recent 
review describes its components and ultrastructure (Turner, 2003).  Briefly, the 
flagellum is comprised of the connecting piece, midpiece, principle piece and end piece.  
A distinguishing characteristic of the midpiece is the existence of accessory structures 
termed outer dense fibers (Fawcett et al, 1975).  There are nine outer dense fibers 
(identified as ODF1 – ODF9) which surround the axoneme and are in close proximity to 
the mitochondria of the sperm tail.  Suggested functions of these fibers have been for 
protection during transport, elasticity of flagellum and general structural support of the 
flagellum (Peterson et al, 1999).  ODF2 has been isolated and has been specifically 
localized in round spermatids of rats (Brohmann et al, 1997).  Beyond the localization 
and apparent structural function of ODF2 in specific species, relatively little is known 
about this protein.  Interestingly, microarray data support the evidence that it is one of 
the most highly up-regulated gene targets in the spermatogenically active testicular 
parenchyma of peri-pubertal stallions and may be a possible predictor of highly fertile 
animals (Ing et al, 2004). 
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Testicular Culture 
 Our knowledge of spermatogenesis and the cellular communications that regulate 
the process has been greatly enhanced over the past century through the use of in vitro 
culture systems.  Multiple reviews clearly state their usefulness in understanding 
pathways, modification of germ cells and treatment of male infertility (Orth et al, 1998; 
Parks et al, 2003).  Their clear advantage is the establishment of controlled environments 
which enable researchers to test for specific mechanisms without compromising normal 
structural relationships.  However, their use has proven problematic due to an inability to 
maintain cell viability for extended periods of time and the need to supply uniform 
access of media and compounds to the tissues. 
Precision-cut tissue slice (PCTS) in vitro culture 
 The first described tissue culture system for investigating testicular cells utilized 
rabbit testis in blood plasma (Champy, 1920).  Since that time, there have been 
numerous advances in the use of different types of culture systems for in vitro studies of 
spermatogenesis (Staub, 2001).  One of the more promising systems for evaluating 
spermatogenesis in vitro utilizes slivers of whole organs placed on wire mesh grids and 
incubated in culture vessels (Smith et al, 1985).  The advantage of the precision-cut 
system is the reproducibility from mechanical tissue slicing, the ability to use organ 
slices that mimic systems in vivo, and the maintenance of tissue architecture (Parrish et 
al, 1995).  To date, this culture system, known as the precision-cut tissue slice (PCTS) in 
vitro culture system, has been used successfully in several tissues such as liver, kidney, 
lung and heart (Parrish et al, 1995; Turney et al, 1999).  In addition, the multiple animal 
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models that have used the PCTS in vitro culture system to investigate physiological 
responses in tissue help strengthen the possible use of this tool as a viable testicular 
culture system.  These studies have included in vitro challenges of various compounds 
on mice liver slices, rabbit renal slices and human prostate slices (Parrish et al, 1999a; 
Turney et al, 1999; Schmelz et al, 2001; Parrish et al, 2002).  This research report 
intends to demonstrate that this system is a capable tool for investigation of whole 
testicular stallion tissue.  Validation of this in vitro system for testicular tissue will 
facilitate studies to investigate mechanisms which regulate expression of genes that are 
involved in spermatogenesis. Ultimately this system could be used to answer some of the 
undefined questions in male fertility and subfertility in all mammalian species. 
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CHAPTER III 
DIFFERENTIALLY EXPRESSED GENES IN TESTICULAR TISSUE OF 
STALLIONS OF VARYING SPERMATOGENIC CAPABILITY AND SEMEN 
QUALITY* 
Introduction 
 The initiation of spermatogenesis begins with a gradual series of events that 
transform the relatively inactive male gonad into an organ that produces high levels of 
testosterone and mature spermatozoa. Spermatogenesis in the colt (young stallion, an 
intact male) initiates in the central region of the testis around the second year of life and 
spreads peripherally until the entire testis is spermatogenically active.  Spermatogenic 
activity can be noted grossly by the light tan color of the central testicular parenchyma in 
the 1.5-year-old horse, while peripheral tissues of the testis are dark red-brown 
(Clemmons et al, 1995). Histologically, dark testis tissues are laden with Leydig cells 
and large macrophages in the interstitial spaces and have small seminiferous tubules that 
are not producing sperm and that occupy no more than 50% of the parenchyma 
(Clemmons et al, 1995). In contrast, light testis tissues have reduced densities of Leydig 
cells, macrophages, and other interstitial cells as the seminiferous tubules (which are 
composed primarily of nonpigmented cells) increase in size and cell density to compose 
____________ 
* Reprinted and modified with permission from “Gene Expression in the Spermatogenically 
Inactive „„Dark‟‟and Maturing „„Light‟‟ Testicular Tissues of the Prepubertal Colt” by NH Ing, 
AM Laughlin, DD Varner, TH Welsh, JR., DW Forrest, TL Blanchard, L Johnson, 2004. 
Journal of Andrology, 24:535-544, Copyright 2004 by The American Society of Andrology. 
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Approximately 70% of the testis parenchyma.  Thus, the prepubertal colt testis presents 
an excellent model for functional genomics to identify genes that are turned on or off 
during the initiation of spermatogenesis. Its adjacent dark and light tissues have similar 
organizational components, including Leydig cells, seminiferous tubules, and influences 
of systemic hormones, but they differ in tubule maturity and function; namely, the 
initiation of spermatogenesis in the light tissue (Clemmons et al, 1995). The long-term 
goal of this study is to better understand the gene regulation critical to spermatogenesis 
and to identify new therapeutic approaches to enhance male fertility. 
 We hypothesize that key genes are involved in spermatogenesis and/or 
steroidogenesis and are differentially expressed in testicular tissues from horses of 
varying spermatogenic states as a result of regulation by hormones, growth factors and 
receptors.  Initially, 12 gene products were chosen that were predicted to be 
differentially expressed in dark and light testis tissues.  These gene products included 
androgen receptor, progesterone receptor, estrogen receptors alpha and beta, steroid 
hormone receptor coactivator 1, high-density lipoprotein binding protein, transforming 
growth factor (TGF) beta 1, 2, and 3, oxytocin receptor, 33lyceraldehydes phosphate 
dehydrogenase, and c-fos.  Of the 12, androgen receptor and TGF beta 1 appeared to be 
differentially expressed, but this was not confirmed on in situ hybridization or Northern 
blots. 
 For this reason we turned to microarrays on glass slides in order to 
simultaneously and efficiently compare levels of expression of 9132 gene products 
between matched dark and light testis tissues of three colts (Study 1A) and testicular 
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parenchyma of two mature stallions (Study 1B) of which one was classified as fertile 
and the other subfertile based semen evaluation (Rockett et al, 2001b; Schultz et al, 
2003).  In situ hybridization and Northern blot analysis confirmed and localized the 
differential regulation of gene products chosen for these analyses.  These discoveries 
open investigations into novel pathways that regulate spermatogenesis.  Importantly, 
these data also demonstrate that analysis of equine gene expression can be performed 
using human cDNA microarrays because of a high level of sequence conservation.  This 
conservation is evident in analyses of 193 horse cDNAs from a testis library that 
displayed an average of 92% identity between horse and human sequences (L. Skow, 
personal communication). 
Materials and Methods 
Animals and sample preparations 
 Seven 1.5-year-old colts and two mature stallions were castrated by standard 
surgical means under appropriate anesthesia.  Testes were cut midsagittally, and gross 
dissection of dark (where appropriate) and light tissues from each testis preceded 
mincing, snap freezing in liquid nitrogen, and storage at -80°C. Five left testicular 
samples were used for microarrays, four different testes were used for Northern blot 
analyses, and all seven colt samples were used for in situ analyses.  Colt testes samples 
were consistent across all horses with regard to age and presence of meiosis, as indicated 
by spermatocytes in light tissues. PolyA+ RNA was isolated directly from dark and light 
tissue samples from all seven young horses and from the two mature stallions with the 
Fasttrack kit (Invitrogen, San Diego, CA). Testes were fixed in 4% paraformaldehyde in 
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phosphate-buffered saline (PBS) (pH 7.2) and embedded in Paraplast (Fisher Scientific, 
Houston, Tex) for in situ hybridization. Reagents were of molecular biology grade and 
purchased from Sigma Chemical Company (St Louis, MO), unless otherwise noted. All 
animal procedures were approved by the Texas A&M University Animal Care and Use 
Committee. 
Microarrays 
 Poly A+ RNA samples from all horses appeared of high quality and purity on an 
ethidium bromide–stained Northern gel (results not shown).  Testis RNA samples (1.8 
mg each) were reverse transcribed and labeled with 5‟Cy3 and Cy5 fluors, respectively; 
hybridized to immobilized human cDNAs of the UniGEM Human V 2.0 microarray; and 
analyzed by Incyte (St Louis, MO).  Probe labeling reactions were incubated at 37°C 
with 200 ng of polyA+ RNA, 200 units M-MLV reverse transcriptase (Life 
Technologies, Gaitherburg, Md), 4 mM DTT, 1 unit Rnase Inhibitor (Ambion, Austin, 
TX), 0.5 mM dNTPs, and 2 mg of labeled 9-mers for 2 hours. Sample amplification was 
not used in order to decrease artifacts in expression ratios. The probe samples were then 
combined, purified, precipitated, and allowed to competitively hybridize to a single 
microarray. Briefly, the hybridization protocol consisted of the following: resuspension 
of probe solution with a five minute incubation at 65°C, application to array, cover 
slipping, and sealing in an evaporation chamber for 6.5 hours at 60°C. After 
hybridization, the glass slides were washed in three consecutive washes of decreasing 
ionic strength. The microarrays consisted of 9132 genes generated from polymerase 
chain reaction (PCR) products (15% were expressed sequence tags) and included 190 
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controls. The fluorescence data was converted to „„balanced difference‟‟ values 
(balanced to account for differences in fluorescence labeling between the cDNA pools) 
with GEMTools 2.4 (Incyte Pharmaceuticals Inc, Palo Alto, CA).  In Study 1A, balanced 
differences with positive values are ratios of signals from the dark testis tissue to light 
testis tissue (Cy3/Cy5).  Negative balanced difference values indicate that the ratio is 
inverted, with the larger light testis tissue (Cy5) signals divided by the lesser dark tissue 
signals (Cy3).  Positive values in Study 1B represent balanced differences of genes more 
highly expressed in the subfertile stallion and negative values indicate genes more highly 
expressed in the fertile animal.  Normalization was performed per chip to a series of 
internal controls including yeast cDNAs and fluorescent standards by gridding and 
region detection algorithms. Gene products with balanced difference values of equal to 
or more than 1.7 or less than -1.7 were considered differentially expressed in both 
studies (P< .05) (Yue et al, 2001; Moody et al, 2002; Reynolds, 2002).  Spots failing to 
meet minimal criteria (signal strength 2.5 times that of background and covering at least 
40% area of the spot) were given balanced difference values of 0 and were excluded 
from evaluation.  Differentially expressed genes were identified with GeneSpring 4.0.2 
software (Silicon Genetics, Redwood City, CA).  
Cloning of down-regulation of ovarian cancer 1 (DOC1), golgi apparatus protein 1 
(GLG1), cell division cycle 2 (CDC2), steroidogenic acute regulatory protein (StAR) 
cDNAs from horse testis 
 To make high-specificity probes for androgen receptor (AR), down regulated in 
ovarian cancer 1 (DOC1), Golgi apparatus protein 1 (GLG1), cell division cycle 2 
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(CDC2), and steroidogenic acute regulatory protein (StAR) mRNAs of the horse, 
cDNAs were cloned from horse testis, as previously described (Ing et al, 1996).  PolyA+ 
RNA (200 ng) was reverse transcribed at 42°C with Superscript II (Life Technologies, 
Newark, NJ) and random hexamer primers. PCR was performed twice with two sets of 
primers designed from human cDNA sequences with the set of primers used for the 
second amplification nested inside the first. cDNAs were cloned into the PCR2.1 vector 
(Invitrogen, Austin, TX), and multiple clones were sequenced. The horse DOC1, GLG1, 
CDC2, and StAR protein cDNA sequences are in GenBank (accession numbers 
AY349169, AF547432, AF547431, and AY349170, respectively). 
Northern analysis of dysferlin (DYS), DOC1, outer dense fiber of sperm tails (ODF2), 
phosphodiesterase 3B (PDE3B), and 37lyceraldehydes-3-phosphate dehydrogenase 
(GAPDH) mRNAs 
 PolyA+ RNA samples (5 mg) were analyzed on a denaturing (Northern) gel, as 
previously described (Ing et al, 1996). RNA Millennium Markers from Ambion (Austin, 
TX) were run alongside. The RNA on the gels was transferred to nitrocellulose 
membranes and the blots were hybridized to radiolabeled antisense cRNA probes 
produced by in vitro transcription (T3 RNA polymerase) with the Maxiscript kit 
(Ambion, Austin, TX) using [32P]-UTP (3000 Ci/mmol; New England Nuclear, Boston, 
MA). The cDNA template for DOC1 was a PCR product (described above), while those 
for dysferlin (DYS), outer dense fiber of sperm tails (ODF2), phosphodiesterase 3B 
(PDE3B), and GAPDH were constructed from linearized plasmids as follows.  Human 
DYS plasmid (pINCY-4462162 vector; Incyte Genomics, Palo Alto, CA) was linearized 
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with EcoR1 and transcribed with T7 RNA polymerase; rat ODF2 plasmid (pBluescript II 
vector) (GenBank accession number U62821) was linearized with Nco1 and T7 RNA 
polymerase; human PDE3B plasmid (pBluescript II vector) (GenBank accession number 
U38178) with BamH1 and T3 RNA polymerase; and ovine GAPDH plasmid restricted 
with BamH1 and T7 RNA polymerase. After stringent washing, the blots were exposed 
to x-ray film (XAR, Kodak, Rochester, NY). Densitometry with Intelligent Quantifier 
software (Bio Image, Ann Arbor, MI) was used to compare hybridization signals 
between samples and reported as an average fold change in densitometric units across 
four horses. Individual gene expression units were normalized to GAPDH to account for 
loading differences. 
In situ hybridization 
 The mRNA for DYS, ODF2, and DOC1 were localized on serial cross sections 
from the left testes of 1.5-year-old horses by in situ hybridization analysis, as described 
previously (Ing et al, 1997). Tissue sections were hybridized with radiolabeled antisense 
or sense cRNA probes generated using in vitro transcription with α[35S]-UTP (1250 
Ci/mmol, New England Nuclear, Boston, MA).  The human DYS plasmid (pINCY-
4462162 vector, Incyte) linearized with EcoRI and transcribed with T7 RNA polymerase 
to produce antisense cRNA.  In addition, negative control sense cRNA from DYS was 
produced from Not1 and SP6 RNA polymerase.  Rat ODF2 and human PDE3B cDNAs 
(GenBank accession numbers U62821 and U38178) were restricted within the cDNAs 
with Nco1 for ODF2 and with BamH1 for PDE3B and transcribed with T7 or T3 RNA 
polymerase for antisense and sense cRNAs. Antisense and sense horse DOC1 cRNAs 
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were produced from PCR products (described above) with T3 and T7 RNA polymerases, 
respectively. After hybridization, washing, and ribonuclease A digestion, slides were 
coated with photographic emulsion (Eastman Kodak, Rochester, NY) and developed two 
or four weeks later, depending on hybridization signal strength. Cell nuclei were 
counterstained with 0.1% toluidine blue. Micrographs were captured on a Zeiss 
Axioplan 2 Microscope (Gottingen, Germany) using Adobe Photoshop (Adobe Systems, 
Seattle, WA). 
Results 
Microarray analyses identify a wide variety of expressed genes 
 The complete data sets (Study A1) from the microarray studies are available 
online at http://animalscience.tamu.edu/ning/microarraydata/horse1.html for „„horse1‟‟ 
and adjacent websites for „„horse2‟‟ and „„horse3‟‟ (summarized in Table 1). Genes are 
grouped and ranked by average balanced difference values.  Two clear results generated 
from the microarray analysis determined that the majority of genes were not 
differentially expressed between dark and light tissues of the testes, and individual 
horses had unique differences in their patterns of testicular gene expression. However, 
there were a number of genes that appeared to be preferentially expressed in dark or light 
tissue. DYS, DOC1, and GLG1 genes were preferentially expressed in dark tissue, while 
ODF2 and PDE3B genes were more highly expressed in light testis tissue of all 3 horses 
analyzed by microarrays (>1.7 balanced difference value, Incyte GEMTools software).  
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Table 1.  Differentially expressed genes in dark/ light testis of prepubertal colts.* 
 
    
 
 
 
 
 
 
 
 
         
        
 
 
 
 
 
 
        *   Differentially expressed genes in dark and light testis
                            tissues from at least 2 of the 3 horses are shown. 
             Numbers represent balanced difference values for gene 
              products considered differentially expressed. 
        ** Indicates genes differentially expressed in both 
             microarray experiments. 
         †  Indicates genes differentially expressed in all 3     
                                   horses.      
         ‡  Indicates average of only 2 usable balanced  
             difference values. 
            Bold identifies genes further studied 
DARK-SPECIFIC 
Signaling Molecules 
3.6 – Insulin-Like Growth Factor 2 (IGF2)   
3.6 – Parathymosin–Cell Cycle Regulated (PTMS)  
2.1 – ATP-Binding Cassette 3 (ABCA3)   
1.9 – CDC-Like Kinase 1 (CLK1)    
1.9 – Major Histocompatibility Complex, Class 1, B  
          (HLA-B)  
1.8 – Insulin-Like Growth Factor Binding Protein 7 
          (IGFBP7)  
1.8 – Protein Kinase D1 (PRKD1)   
1.8 – CD63 Molecule (CD63)  
1.7 – Major Histocompatibility Complex, Class 1, C (HLA-C) 
1.7 – Transmembrane Protein 194A (TMEM194A)  
1.5 – Methyl-CPG Binding Domain Protein 3 (MBD3)  
1.4 – Major Histocompatibility Complex, Class 1, G (HLA-G) 
Cytoskeleton & Adhesion Molecules 
4.1 – Desmoplakin (DSP) 
3.7 – Dysferlin, Limb Girdle Muscular Dystrophy 2B 
          (autosomal recessive) (DYS) †  
3.0 – Laminin, β1 (LAMB1)   
2.8 – Keratin  8 (KRT8)   
2.5 – Golgi Apparatus Protein 1 (GLG1) † ** 
2.3 – Downregulated in ovarian cancer (DOC1) † 
2.2 – Keratin 18 (KRT18)  
2.1 – Absent in Melanoma 1 (AIM1)   
2.0 – Mitochondrial Ribosomal Protein L13 & L    
          (MRPL13) (MRPL) 
1.9 – Crystallin, mu (CRYM) 
1.9 – Ribosomal Proteins L3 & L6 (RPL3 ) (RPL6) 
1.9 – Sarcoglycan (SGCG) 
1.9 – Septin 8 (SEPT8) 
1.8 – Calponin 3, Acidic (CNN3) 
1.8 – Cadherin 3, Type 1, (placental) (CDH3) 
1.8 – SATB1 Homeobox 1 (SATB1) 
1.8 – Ribosomal Proteins L9, L12, S14 (RPL9) (RPL12) 
          (RPS14) 
1.7 – Ribosomal Proteins Large P0 & S3, S7, S10, S23 
          (RPLP0) (RPS3) (RPS7) (RPS10) (RPS23) 
1.6 – Ribosomal Protein S15a (RPS15A) 
Enzymes & Inhibitors 
2.5 – 24-Dehydrocholesterol Reductase (DHCR24) ** 
2.3 – O-Linked N-Acetylglucosamine Transferase (OGT) 
2.1 – HECT and WWE Domain Containing 1 (HUWE1) 
2.0 – Glutathione-S-Transferase Ω (GSTO1)  ** 
2.0 – Mesoderm Specific Transcript Homolog (MEST)  
1.9 – Carboxypeptidase E (CPE)   
1.9 – Argininosuccinate Synthetase 1 (ASS1) 
1.8 – Phospholipase D2 (PLD2)   
1.8 – Protein S (Alpha) (PROS1)   
1.8 – Ribonuclease, RNASE A Family 9 (RNASE9)  
1.8 – ATPASE, Na+/K+ Transporting, 2 Polypeptide      
          (ATP1A1) 
1.8 – Vaccinia Related Kinase 1(VRK1)   
1.8 – Serpine Peptidase Inhibitor, Clade A, 5 (SERPINA5) 
1.7 – Cardiomyopathy Associated 5 (CMYA5) 
1.7 – Serpine Peptidase Inhibitor, Clade G, 1 (SERPING1) 
1.6 – Sterol-C4-Methyl Oxidase-Like (SC4MOL) ** 
1.6 – Eukaryotic Translation Elongation Factor 1 β 2 
          (EEF1B2) 
1.6 – Muscleblind (drosophila)-like (MBNL1) 
1.5 –Transcription Factor 4 (TCF4)  
 
LIGHT-SPECIFIC  
Signaling Molecules 
-5.0 – Cyclin A 1 (CCNA1) 
-2.5 – Serine/Threonine Kinase 24 (STK24) 
-2.3 – Cell Division Cycle 2  (CDC2) ** 
-2.3 – Interferon, alpha Inducible Protein 6 (IFI6) ** 
-2.2 – A Kinase (PRKA) Anchor Protein 12  
           (AKAP12) 
-2.2 – CBP/P300-Interacting Transactivator with Glu/ 
           Asp-rich carboxy-terminal 1 (CITED1) ** 
-2.0 – CDC28 Protein Kinase 2 (CKS2) 
-2.0 – Guanine Nucleotide Binding Protein, δ3 
           (GNG3) ** 
-1.9 – Phospholipase C, δ 1 (PLCD1) 
-1.8 – Cholecystokinin (CCK) 
-1.8 – Sortilin 1 (SORT1) 
-1.6 – Angio-Associated, Migratory Cell Protein 
           (AAMP) 
-1.6 – Purine-Rich Element Binding Protein B 
          (PURB) 
-1.6 – PRKC, Apoptosis, WT1, regulator  (PAWR) 
Cytoskeleton & Adhesion Molecules 
-7.8 – Outer Dense Fiber of Sperm Tails 2  
           (ODF2) † 
-7.7 – Protamine 1 (PRM1) 
-4.4 – Calmegin (CLGN) 
-4.0 –  ‡  Claudin 11 (CLDN1) 
-2.2 – Kinesin Family Member 11 (KIF11) 
-2.0 – Budding Uninhibited by Benzimidazoles 1 
            Homolog beta (BUB1B) 
-2.0 –  ‡ Tripartite motif-containing 9 (TRIM9) 
-1.7 – Contactin 2  (CNTN2) 
-1.7 – Stathmin 1 (STMN1)  
-1.6 – Tubulin, alpha 4A (TUBA4) 
Enzyme & Inhibitors 
-4.4 – Phosphodiesterase 3B, cGMP-Inhibited  
           (PDE3B) † 
-3.3 – Glycerol Kinase (GK) 
-2.8 – Hydroxyacyl Glutathione Hydrolase (HAGHL) 
-2.7 –   ‡ mutS Homolog 4 (E. Coli) (MSH4) 
-2.5 – Exonuclease NEF sp (RGD1305412) 
-2.3 – Coagulation Factor C (PROC) 
-2.3 – Solute carrier family 2 (facilitated glucose                                   
           transporter), member 4 (SLC2A14) 
-2.2 – Phosphorylase Kinase, γ 2 (testis) (PHKG2) 
-1.8 – Serpine peptidase inhibitor, clade F (alpha-2 
           antiplasmin, pigment epithelium derived 
           factor), member 1 (SERPINF1) ** 
-1.8 – Forkhead Box G 1 (FOXG1) 
-1.8 – Signal peptidase complex subunit 1 homolog 
           (SPCS1) 
41 
 
   
 An additional 88 genes appeared to be regulated differently between light and 
dark testis tissue in at least 2 of the 3 horses analyzed. These genes fall into a number of 
different functional categories, including 1) signaling molecules; 2) cytoskeletal and 
adhesion molecules; and 3) enzymes and inhibitors. These gene products and their 
official symbol (provided in parenthesis following gene names) are shown in Table 1 
ranked by their balanced difference values averaged across all three prepubertal 
microarray analyses (number to the left of the gene name). Larger absolute values of 
balanced differences related to larger magnitudes of differential gene expression. For 
example, the largest (-7.8) was for ODF2, indicating that light testis tissue had 7.8-fold 
more ODF2 mRNA than the dark tissue of the testis. In total, 93 genes appeared to be 
differentially expressed based on microarray results. These included 58 genes 
preferentially expressed in dark testis tissue (left panel) and 35 genes preferentially 
expressed in light testis tissue (right panel).  These 93 genes were only 1.3% of the 6940 
gene products that had hybridization signals that met minimal criteria on at least 2 
microarrays. 
  These microarray results indicated differential expression of many interesting 
genes. In the cell-signaling group, the insulin system was implicated, with insulin-like 
growth factor 2 and insulin-like growth factor binding protein 7 being predominantly 
expressed in dark tissue, whereas PDE3B was expressed more in light tissue. Gene 
products that regulate cell cycle progression were also differentially expressed. These 
included parathymosin and CDC like kinase in dark tissue and cyclin A1, CDC2, 
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CDC28 protein kinase 2, budding uninhibited by benzimidazoles 1 homolog beta, and 
PRKC, apoptosis, WT1, regulator  (PAWR) in light tissue. 
 There were many differences in the expression of genes whose products had 
cytoskeletal or cell adhesion functions.  For example, dark testis tissue expressed higher 
levels of desmoplakin, keratins, and cadherin mRNAs, the products of which are 
associated with intermediate filaments, as well as myosin-like DOC1, sarcoglycan, and 
calponin gene products, which are associated with large cytoskeletal filaments.  Cell 
adhesion proteins laminin and GLG1 were also predominately expressed in dark testis 
tissue, as were two glyceraldehyde genes.  Light testis expressed higher levels of gene 
products associated with sperm-specific structures (ODF2 and protamine 1) and 
microtubules (kinesin-like 1, stathmin, and the testis-specific tubulin A1).  In addition, 
metabolic enzymes, kinases, protease inhibitors, and transcription factor genes were 
differentially expressed between dark and light tissues. 
 Study 1B analyzed the differences in gene expression in testicular parenchyma 
between an adult stallion with high fertility (designated as fertile stallion) and an adult 
stallion with reduced fertility (designated as subfertile stallion).  Using similar criteria as 
in Study 1A with a ±1.7 balanced difference threshold value for genes to be 
differentially expressed, 233 gene products appeared to be differentially expressed.  Of 
these, 122 genes appeared to be more highly expressed in the fertile stallion while 111 
appeared more highly expressed in the subfertile stallion.  Table 2 summarizes 30 of the 
genes found in the microarray study using a fertile stallion and a stallion with reduced 
fertility that met at least a 2.0 or greater minimum balanced difference.  In this
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 Table 2.  Differentially expressed genes in a fertile and subfertile stallion.* 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                                                                                *    Gene products with a balanced difference value  
                                                                                                                              of  ± 2.0 or greater are shown to the right of each  
 gene name. 
 
                                                                                                                        **  Indicates genes differentially expressed in both 
                                                                                                                              microarray experiments. 
 
 Bold represents the two gene products with the  
  highest balanced difference value in this 
 experiment. 
 
 
 
 
  
 
 
 
FERTILE STALLION 
 
Signaling Molecules 
 
-2.4 - 5-Hydroxytryptamine (serotonin) Receptor 4 
          (HTR4)  
-2.2 - Pre-B-cell Leukemia Homeobox Interacting Protein 
          (PBXIP1) 
-2.1 - Zinc Finger E-box Binding Homeobox 2 (ZEB2)  
-2.0 - Cbp/p300-interacting transactivator, with  
           Glu/Asp-rich carboxy-terminal domain, 1 
          (CITED1) ** 
-2.0 - Forkhead Box O3 (FOXO3) 
-2.0 - Low Density Lipoprotein Receptor-Related Protein 
           Associated Protein 1(LRPAP1) 
-2.0 - Interferon, alpha-Inducible Protein 6 (IFI6) **  
-2.0 - Pre-B-Cell Leukemia Homeobox (PBX1) 
 
Cytoskeleton & Adhesion Molecules 
 
-2.6 - Selenium Binding Protein 1(SELENBP1) 
-2.4 - ATP-Binding Cassette, sub-family F (GCN20), member 2 
          (ABCF2) 
-2.3 - Plakophilin 4 (PKP4) 
-2.1 - Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) 
          (SPTAN1) 
-2.0 - Catenin (cadherin-associated protein), alpha-like 1 
          (CTNNAL1) 
-2.0 - Catenin (cadherin-associated protein), beta 1, 88kD 
          (CTNNB1) 
-2.0 - Fibulin 2 (FBLN2) 
 
Enzymes & Inhibitors 
 
-4.9 - Rho-Associated, Coiled-Coil Containing Protein   
           Kinase (ROCK1) 
-2.9 - 24-Dehydrocholesterol Reductase (DHCR24) ** 
-2.5 - Cytochrome P450, Family 17, Subfamily A,  
          Polypeptide (CYP17A1)    
-2.1 - Serpine Peptidase Inhibitor, Clade F (alpha-2 
           antiplasmin, pigment epithelium derived factor),  
           Member 1 (SERPINF1) ** 
-2.0 - Cytochrome P450, Family 11, Subfamily A, 
          Polypeptide (CYP11A1) 
 
 
 
SUBFERTILE STALLION  
 
Signaling Molecules 
 
   2.0 - BTB (POZ) domain containing 9 (BTBD9) 
 
Cytoskeleton & Adhesion Molecules 
 
      2.4 - Phosphatidylinositol Glycan, Class K 
(             (PIGK) 
                2.1 - Origin Recognition Complex, Subunit 6 like 
             (ORC6L) 
   2.0 - Ankyrin Repeat Domain 36 (ANKRD36) 
              2.0 - DAZ Interacting Protein 1 (DZIP) 
   2.0 - Hypothetical Brain Protein MY040 (MY040) 
                 2.0 - Stress-Associated Endoplasmic Reticulum 
                         Protein (SERP1) 
 
Enzyme & Inhibitors 
 
 2.5 - Arginase, Type II (ARG2) 
   2.0 - ATP Synthase, H+ Transporting, 
            Mitochondrial F0 Complex, Subunit B1 
            (ATP5F1) 
   2.0 - Telomerase Reverse Transcriptase (TERT) 
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microarray, the two gene products with the highest differential expression values were 
Rho-associated, coiled-coil containing protein kinase, also known as ROCK1 (-4.9 in 
fertile tissue), and 24-dehydrocholesterol reductase (DHCR24), (-2.9 in fertile tissue). 
One of the genes that we further studied was StAR protein (not shown in Table 2) but 
was found to be more highly expressed in the fertile stallion (-1.7 in fertile tissue) 
compared to the subfertile stallion. 
 Additionally, results of the microarrays unveiled nine genes that were 
differentially expressed in both the light/dark and fertile/subfertile experiments 
(Appendix A).  These genes included Golgi apparatus protein 1 (GLG1) (-1.8 in fertile 
tissue and 2.5 in dark tissue), glutathione-S-transferase (GSTO1) (-1.8 in fertile tissue 
and 2.0 in dark tissue), guanine nucleotide binding protein (GNG3) (-1.8 in fertile tissue 
and -2.0 in light tissue), cell division cycle 2 (CDC2) (1.7 in subfertile tissue and -2.3 in 
light tissue), serpine peptidase inhibitor, clad F, member 1 (SERPINF1) (-2.1 in fertile 
tissue and -1.8 in light tissue), sterol-C4-methyl oxidase-like (SC4MOL) (-1.7 in fertile 
tissue and 1.6 in dark tissue), 24-dehydrocholesterol reductase (DHCR24) (-2.9 in fertile 
tissue and 2.5 in dark tissue), interferon, alpha-inducible protein (IFI6) (-2.0 in fertile 
tissue and -2.3 in light tissue) and Cbp/p300-interacting transactivator, with Glu/Asp-
rich carboxy-terminal, domain 1 (CITED1) (2.0 in fertile tissue and 2.2 in light tissue).  
Of the nine gene products expressed in both microarray experiments, four candidate 
genes (GNG3, SERPINF1, IFI6 and CITED1) were preferentially expressed in both the 
light parenchyma and in the fertile testis of stallions. These results suggest that these 
gene products could be potential markers of fertility in the stallion.  GNG3 is a guanine 
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nucleotide-binding protein and is associated with the gamma subunit of G proteins 
which are involved in cell signaling (Hurowitz et al, 2000).  Knockout mice for GNG3 
demonstrate increased seizure activity and decreased body weight and overall adipose 
deposition when compared to controls (Schwindinger et al, 2004).  SERPINF1 is an 
inhibitor of angiogenesis, also known as pigment epithelium-derived factor (PEDF), and 
is a member of the serine protease inhibitor family.  Using knockout mice for PEDF as 
models, Doll and colleagues (2003) showed that fertility was unaffected and that 
treatment of prostate cells in culture with androgens inhibited the expression of PEDF.  
The functions of IFI6 and CITED1 are currently unknown and warrant further 
investigation as to their role in the testis.  The other five gene products preferentially 
expressed in both microarrays included DHCR24, GSTO1, GLG1, SC4MOL, and 
CDC2.  The functions of these gene products are challenging to understand because their 
balanced differential expression appears contradictive as they were found in dark 
parenchyma and fertile tissue (DHCR24, GSTO1, GLG1, and SC4MOL) or in light 
parenchyma and subfertile tissue (CDC2).  DHCR24 is the most studied of this group 
and is an enzyme that converts sterols to cholesterol, a precursor to the production of 
steroid hormones (Wechsler et al, 2003).  In mice lacking the DHCR24 gene, males 
showed normal organ development except in the testes which exhibited premature 
testicular degeneration rendering these mice infertile (Wechsler et al, 2003).  GSTO1 is 
also an enzyme and has been reported to play a role in the detoxifying process of cells 
(Board et al, 2000).  Little is known about the functions of GLG1, a protein associated 
with transport in the Golgi apparatus or with SC4MOL (Mourelatos et al, 1995).  It 
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could be that these genes are initially involved lumen development of seminiferous 
tubules in dark testis tissue and later aid in the regulation of normal tubule maintenance 
in fertile stallions; however, more studies of these genes are needed.  CDC2, found to be 
up-regulated in light parenchyma and subfertile tissue, is a cell cycle regulator involved 
with entry into mitosis and studies involving rats have shown that CDC2 induces 
apoptosis (Konishi et al, 2002).  The up-regulation of CDC2 in light parenchyma of 
peripubertal stallions compared to dark parenchyma could be due to the presences of 
newly formed germ cells (namely spermatocytes and spermatids) found in 
spermatogenically active light tissue.  The higher expression of the CDC2 gene product 
in subfertile tissue could be a result of low levels of cell division kinases (CDKs) which 
when present bind to CDCs giving the newly formed complex phosphoralytive 
properties (Lee et al, 1988).  Collectively, these nine gene candidates need further 
investigation as they have the potential to provide important information about 
molecular functions in the stallion testis. 
Northern blots confirm differential expression of DYS, DOC1, ODF2, and PDE3B genes 
in light and dark testes tissues 
 Northern blots were used to confirm the differential expression of DYS, DOC1, 
ODF2, and PDE3B genes between light and dark testis tissues, utilizing GAPDH 
mRNAs as a control. Representative Northern blots are depicted in Figure 1.  In order to 
critically analyze and verify these results, horses evaluated were not used in the 
microarray. Both DYS (8.0 kb) and DOC1 (3.5 kb) mRNA concentrations are greater in 
dark testis tissue compared to light. Previous Northern blot experiments indicate similar 
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sizes for those mRNAs (Mok et al, 1994; Britton et al, 2000).  In contrast, ODF2 and 
PDE3B mRNAs hybridized weakly in dark tissue but showed strong expression in the 
light tissue. Sizes of these transcripts (2.5 and 6.5 kb, respectively) were similar to those 
observed in other studies (Miki et al, 1996; Schalles et al, 1998). Similar Northern blot 
analyses of light and dark testis tissue RNA samples of four horses were quantitated. 
Since there were no differences in GAPDH mRNA concentrations found between light 
and dark tissues of other stallions in macroarray, in situ hybridization, or microarray 
analyses, each lane was normalized to its GAPDH mRNA signal and is reported as mean  
fold change for each mRNA (±SE). Fold differences on Northern blots were comparable 
to signal intensities for microarrays.  Mean fold changes in dark versus light tissues for 
DYS and DOC1 mRNAs were 3.2 (±0.44) and 2.4 (±0.27), whereas ODF2 and PDE3B 
both exhibited fold increases in light over dark tissue at 4.6 (±1.6) and 3.9 (±1.2), 
respectively. 
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Figure 1. Representative Northern blot analyses of mRNA in dark and light regions of testes 
from 1.5-year-old horses.  PolyA+ RNA was isolated from light (L) spermatogenically active 
and dark (D) spermatogenically inactive testicular tissues.  Radiolabeled antisense cRNAs 
specifically hybridized dysferlin (DYS), down-regulated in ovarian cancer 1, myosin-like 
(DOC1), outer dense fiber of sperm tails 2 (ODF2), phosphodiesterase 3B (PDE3B), and 
48lyceraldehydes-3-phosphate dehydrogenase (GAPDH) mRNAs on separate blots at 8.0-, 3.8-, 
2.5-, 6.5-, and 1.8-kb sizes, respectively.  Migration positions of RNA markers are indicated at 
left and ribosomal rRNAs at right. 
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In situ hybridization confirms and localizes differential expression of genes within dark 
and light testis tissues 
 DOC1, human DYS and PDE3B, and rat ODF2 cDNA localization of horse 
mRNA in light and dark testis from 1.5-year-old horses by in situ hybridization indicate 
similar patterns to those obtained by microarray and Northern blot analysis. Like that of 
the horse AR cDNA (GenBank accession number AY032721), the horse cDNA for 
DOC1 was highly conserved across species, being 92% identical to the human.  
Representative brightfield and darkfield views of the in situ hybridization of DYS and 
DOC1 mRNAs are shown in Figure 2. The bright-field views illustrate the histology of 
the testes; dark testis tissue has small seminiferous tubules with closed lumina and light 
tissue has larger seminiferous tubules and open lumina. Hybridization signals (small, 
black silver grains) for DYS and DOC1 mRNAs were markedly stronger in dark testis 
compared to the light tissue (Figure 2) and were concentrated over the seminiferous 
tubules. In contrast, an intense accumulation of signal for ODF2 and PDE3B mRNAs 
(Figure 3) was found in the light tissue over maturing germ cells (Figure 3).  Thus, in 
situ hybridization confirmed the differential expression between dark and light testis 
tissue for four genes analyzed from the 93 genes listed in the Table and Northern blot 
hybridization. 
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Figure 2. In situ hybridization reveals dysferlin (DYS) and down-regulated in ovarian cancer 1 
(DOC1) gene expression predominantly in seminiferous tubules of the dark tissue of a maturing 
horse testis. Adjacent cross sections from a 1.5-year-old horse testis were hybridized with 
antisense cRNA probes for DYS and DOC1. Slides were coated with autoradiographic emulsion 
and developed after 2 or 4 weeks of exposure. Brightfield views (A, E, and I for dark tissue; C, 
G, and K for light tissue) show the nuclei stained lightly with 0.1% toluidine blue. Small silver 
grains shine white in darkfield views and indicate hybridization of radioactive probes for DYS 
(Panels B and D) and DOC1 (Panels F and H) mRNAs. Panels I-L show the low level of 
nonspecific binding to sense DYS cRNA (a negative control). They also clearly demonstrate the 
smaller diameter and lack of open lumina in the seminiferous tubules of the dark testis Panel 
compared to the light testis Panel. The bar in Panel I indicates 100 mm. 
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Figure 3. In situ hybridization localizes the expression of outer dense fiber of sperm tails 2 
(ODF2) and phosphodiesterase 3B (PDE3B) mRNA in developing male germ cells. 
Representative views of adjacent cross sections of a testis hybridized with radiolabeled cRNA 
probes for ODF2 and PDE3B mRNAs. The ODF2 gene is primarily expressed in round and 
elongated spermatids (Panel D), whereas PDE3B mRNA demonstrates very high concentration 
in mature spermatocytes and round spermatids (Panel H). Tissue sections pictured in Panels I–L 
were hybridized to sense ODF2 cRNA (a negative control) and demonstrate the low level of 
nonspecific hybridization. The bar in Panel I indicates 100 mm. 
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Discussion 
 A major finding of these studies was that there are few changes in gene 
expression between light and dark testicular parenchyma or between a stallion of normal 
semen quality (fertile stallion) and a stallion with reduced semen quality (subfertile 
stallion) among the 9132 genes evaluated. The 93 genes identified by the microarrays in 
the light/dark study as being potentially differentially expressed comprised only 1.3% of 
those analyzed.  Similarly, only 2.6% of the genes in the fertile/subfertile microarray 
were differentially expressed.  In the light/dark microarrays, the use of matched tissues 
from the same horse testis provided a „„low noise‟‟ model system that demonstrates how 
few changes in gene expression are concurrent with the initiation of spermatogenesis. 
Similar results on reproducibility and sensitivity of these types of microarrays have been 
reported (Yue et al, 2001; Moody et al, 2002; Reynolds, 2002). 
 The large number of gene products analyzed on the microarrays provided an 
unbiased and feasible method of identifying genes that are regulated during the initiation 
of spermatogenesis. The microarray data yielded expected results that validated the 
analyses. For example, AR and other genes analyzed previously were not differentially 
expressed between dark and light tissues of the horse testes.  However, we were able to 
identify genes regulated during the initiation of spermatogenesis, including DYS, DOC1, 
ODF2, and PDE3B.  Likewise, StAR protein and 24-dehydrocholesterol reductase 
(DHCR24) were found more highly expressed in the fertile stallion, as expected. 
 The DOC1 gene, a candidate tumor suppressor gene with a myosin-like product, 
was also found to be more highly expressed in dark tissue. Interestingly, DOC1 is 
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expressed by normal ovarian epithelial cells but not by ovarian cancer cell lines (Mok et 
al, 1994). Other than involvement with cytoskeletal and adhesion molecules like that of 
DYS, its role in the initiation of spermatogenesis is still unclear. 
 Expression of ODF2 and PDE3B genes is predominant in the spermatogenically 
active horse testis tissue and is described in other species, including the mouse, rat, and 
human (Hoyer-Fender et al, 1998; Wiersma et al, 1998; Peterson et al, 1999; Nakagawa 
et al, 2001). The ODF2 gene is expressed exclusively in the testis and is part of the 
cytoskeletal structure of the sperm tail. The function of ODF2 involves maintaining 
elastic recoil and providing protection from shear forces during sperm transport in the 
female reproductive tract. Equine ODF2 mRNA was localized to mature tubules with 
round and elongated spermatids, which coincides with the results of other studies in the 
rat and bull (Schalles et al, 1998).  PDE3B also showed a definite expression difference 
in light tissue in all experiments conducted and functions to regulate cAMP levels. In the 
mammalian ovary, meiotic arrest of oocytes is regulated by cAMP levels. PDE3B 
enzymatically catabolizes cAMP levels, and when PDE3B is inhibited with products 
such as milrinone and cilostamide, cAMP levels increase and prohibit maturation 
(Wiersma et al, 1998). Also, PDE3B acts as a mediator in the insulin pathway (Harndahl 
et al, 2002). PDE3B mRNA was expressed only in secondary spermatocytes and round 
spermatids, but not in elongated spermatids. These results imply that PDE3B may play 
an important role in meiotic division in the testis. Other genes discovered by the 
microarrays that have greater expression levels in spermatogenically active light testis 
tissue specific to developing male germ cells include protamine, calmegin, tubulin a1, 
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and phosphorylase kinase γ2 (Amat et al, 1990; Prigent et al, 1996; Mochida et al, 1998; 
Yoshinaga et al, 1999; Steger et al, 2001). 
 Upon analysis, it is obvious that cross-species hybridization in cDNA 
microarrays is a strong tool to elucidate important genes involved in spermatogenesis. 
Although initial predictions of which hormone receptors and paracrine factors would be 
regulated during the initiation of spermatogenesis did not prove to be true, other genes 
were identified by the microarray analyses. One example is the CBP/p300 transactivator 
that participates in steroid hormone receptor and c-fos transactivation pathways and was 
preferentially expressed in light testis tissue (Fronsdal et al, 1998). Another example is 
the identification of three genes in the insulin-like growth factor–signaling system, 
which is consistent with the proposed role of this system in testis development and 
seasonal induction of spermatogenesis (Achanzar and Ward, 1997; Fiszer and Kurpisz, 
1998; Liu et al, 1998; Wagoner et al, 2000). 
 Other groups have indicated that some of the gene products identified here are 
important to the biology of the testis (Yu et al, 2003). For example, ODF2, 
cholecystokinin, cyclin A1, calmegin, glucose transporters, and stathmin, predominately 
expressed in light testis tissues, are involved in meiosis and developing male germ cells 
(Persson et al, 1989; Weiss et al, 1997; Angulo et al, 1998; Flores et al, 1998; Ohsako et 
al, 1998; Rouiller- Fabre et al, 1998; Schalles et al, 1998; Bushby, 1999; Ravnik and 
Wolgemuth, 1999; Yoshinaga et al, 1999; Doege et al, 2000; Muller et al, 2000; Tsuruta 
et al, 2000; Guillaume et al, 2001). Additionally, placental cadherin and laminin are dark 
testis tissue–specific gene products that others have localized to peritubular cells and the 
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basement membranes of seminiferous tubules, respectively (Virtanen et al, 1997; 
Johnson et al, 2000a).  Importantly, altered expression of DYS, kinesin, laminin, and 
protamine genes has been associated with reductions in male fertility and 
spermatogenesis in man and other species (Boekelheide et al, 1989; Lee et al, 1995; 
Virtanen et al, 1997; Mochida et al, 1998; Yoshinaga et al, 1999; Cho et al, 2001; Steger 
et al, 2001). 
 The use of human cDNA microarrays to study gene expression in the horse testis 
was highly successful.  These Incyte microarrays have generated data in both human and 
animal systems that have proven to be reproducible and reliable (Pomp et al, 2001; Yue 
et al, 2001; Moody et al, 2002).  The success of the technique in our studies is due to the 
high level of sequence conservation between horse and human mRNAs.  Cross-species 
hybridization is common in Northern blot and in situ hybridization analyses, as 
demonstrated here even for species as diverse as rat and horse.  Thus, microarrays 
composed of long human cDNAs (not oligonucleotides) provide a valuable tool for gene 
expression analyses in domestic animal species.  Genetic analyses of equine testes were 
uniquely powerful in generating nonbiased lists of new gene targets to explore in the 
developing testis of the prepubertal colt and in stallions with normal and reduced semen 
quality.  By understanding the regulation of the identified gene products within testicular 
cells of immature and mature stallions, we may elucidate the gene networks critical to 
efficient spermatogenesis as well as novel therapeutic approaches for improving male 
fertility. 
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CHAPTER IV 
PDE3B AND StAR PROTEIN GENE EXPRESSION IN TESTES FROM 
NORMAL MATURE STALLIONS AND IMMATURE AND MATURE 
UNILATERAL CRYPTORCHID STALLION TESTES  
Introduction 
 Spermatogenesis is the developmental progress of spermatogonia undergoing 
changes that yield highly specialized male gametes (Weinbauer and Wessels, 1999; 
Johnson et al, 2000b).  Most likely, germ cells contain a specialized genetic program that 
controls the morphological changes.  Steroidogenesis by Leydig cells in the testis is also 
required for spermatogenesis.  One method of investigating specific genes involved in 
this progression is by in situ hybridization.  Two transcripts, phosphodiesterase 3B 
(PDE3B) and steroidogenic acute regulatory protein (StAR) have been identified in this 
complex process in the testis (Reinhardt et al, 1995; Stocco and Clark, 1996; Ing et al, 
2004).  However, regulation of PDE3B and StAR protein gene expression has not been 
fully investigated in the stallion (Equus caballus).  Therefore, the intent of this study was 
to evaluate gene expression differences in the testes of immature and mature horses and 
in unilateral cryptorchid horses.  Unilateral cryptorchids, a congenital condition where 
one testis fails to descend into the scrotum, provide a unique model to study testicular 
function and dysfunction due to the presence of both a descended and retained organ.  
Additionally, we investigated potential relationships between these two genes and 
factors that influence fertility such as gonadal characteristics and circulating 
reproductive hormone levels in mature stallions. 
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 Cyclic nucleotide phosphodiesterases are enzymes that hydrolyze cyclic 
nucleotides (Park et al, 2002).  Of the 11 structurally-related family members, PDE3 is 
unique in its ability to terminate the action of both second messengers guanosine 3‟, 5‟-
cyclic monophosphate (cGMP) and adenosine 3‟, 5‟-cyclic monophosphate (cAMP) 
(Loughney and Ferguson, 1996).  Two members of the PDE3 family have been 
identified (PDE3A and PDE3B) and they have distinct genes located on different 
chromosomes.  PDE3A maps to human chromosome 12 and PDE3B maps to human 
chromosome 11 (Miki et al, 1996).  Northern blots have detected PDE3B mRNA in 
adipose and testicular tissues (Taira et al, 1993; Ing et al, 2004).  Additionally, in situ 
hybridization has demonstrated high levels of expression in adipose tissue of developing 
rats and lower levels of expression in hepatocytes, oocytes, renal collecting duct 
epithelium and spermatocytes of mature animals (Reinhart et al, 1995).  Levels of 
PDE3B mRNA increased with initiation of spermatogenesis in stallion testes (Ing et al, 
2004).  This observation suggests that PDE3B has a role in the regulation of 
spermatogenesis. 
 StAR protein transcripts in the testes have likewise been documented (Pollack et 
al, 1997; Manna et al, 2004; Manna and Stocco, 2005).  StAR protein serves as a 
translocation enzyme necessary for cholesterol delivery to the inner mitochondrial 
membrane initiating steroidogenesis (Sugawara et al, 1995; Caron et al, 1997).  Its 
necessity has been shown in the human condition called congenital lipoid adrenal 
hyperplasia (lipoid CAH).  In patients with lipoid CAH, steroidogenesis is blocked as a 
result of a mutation in the synthesis StAR protein which results in the accumulation of 
58 
 
lipids (Stocco, 2002).  Due to its key regulation of cholesterol trafficking, the temporal 
abundance of this enzyme may affect fertility directly associated with steroid production.  
These results have lead to our further investigation of StAR protein transcripts in the 
stallion testes. 
 The purpose of this study was to demonstrate PDE3B and StAR protein mRNA 
expression differences among mature stallions (testis weight > 150 gm) and unilateral, 
immature, one-year-old and mature, three-year-old cryptorchid stallions.  Additionally, 
we sought to quantify the amount of PDE3B and StAR protein mRNA expression in the 
testis of mature stallions with the intent of measuring the strength of relationship 
between the amount of mRNA expression and fertility parameters such as daily sperm 
production (DSP), daily sperm output (DSO), apoptotic rate and circulating hormone 
levels.  We hypothesized that: (1) in situ hybridization would reveal differences in gene 
expression for PDE3B and StAR protein mRNA in ten mature horses; (2) quantitative 
values from in situ hybridization experiments for PDE3B and StAR protein mRNAs 
would correlate positively with DSP and serum testosterone levels in those stallions; and 
(3) mRNA levels for PDE3B and StAR protein would be elevated in the descended 
testes of three-year-old unilateral cryptorchid stallions compared to one-year-old 
unilateral cryptorchid stallions and that the descended testes of both age groups would 
demonstrate a higher signal intensity compared to the retained testes. 
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Materials and Methods 
Animals and tissue preparations 
 A total of twenty-two different stallion testicular tissue samples were used to 
evaluate gene expression changes of PDE3B and StAR protein mRNA by in situ 
hybridization methodology.  Ten of these were archived left testis samples obtained from 
tissue blocks of mature stallions with normal-sized testes (>150 gm) of which 
measurements associated with fertility had been analyzed prior to castration.  Of this 
population, horses were categorized based on semen quality parameters of progressively 
motile sperm (PMS) and morphologically normal sperm (MNS).  Stallions were 
classified as normal with semen quality parameters >60% PMS and >55% MNS (n=9). 
One stallion (Peppy) was classified as having reduced semen quality because PMS was 
<23% and MNS was <39%.  These samples were used to identify relationships between 
the estimated testicular amounts of PDE3B and StAR protein hybridization signal and 
parenchyma weight (g), DSP/gram of tissue, DSP/testis, DSP/horse, DSO, apoptotic 
rate, and circulating concentrations of testosterone (T), estradiol 17β (EEL), luteinizing 
hormone (LH), follicle stimulating hormone (FSH) and inhibin. 
 The remaining 12 tissue samples used in this study were whole testes from six 
unilateral cryptorchid stallions (three one-year-old stallions and three three-year-old 
stallions).  These samples were harvested from client owned stallions admitted to the 
academic hospital (Large Animal Hospital at Texas A&M University, College Station, 
TX, USA) for elective castration.  Castrations were performed by opened or closed 
surgical methods in lateral recumbence under general anesthesia, using anesthetic 
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regimens preferred by the surgeon and anesthesiologist on duty.  These testes were used 
to determine differences in PDE3B and StAR protein mRNA concentrations between 
normally descended testes and retained testes.  Immediately following tissue collection, 
each testis was weighed and testicular parenchyma (2 cm x 2 cm x 4 mm) was removed 
and fixed by 24 h immersion with rocking in 4% paraformaldehyde in phosphate-
buffered saline (PBS) (pH 7.2).  Samples were then stored in 70% ethanol and embedded 
in Paraplast (Fisher Scientific, Houston, TX, USA) and sectioned for in situ 
hybridization studies. 
 Companion studies have previously described the methodology for determining 
DSO, DSP and apoptotic rates (Johnson and Thompson, 1986; Blanchard and Johnson, 
1997; Heninger et al, 2004; Forrest et al, 2006).  Briefly, DSO was estimated from the 
mean value of three daily ejaculate collections after seven prior daily ejaculates to clear 
stored sperm.  DSP estimations were conducted by counting elongated spermatids 
following homogenization and DSP per testis was calculated from DSP/g and testis 
weight.  The TUNEL (TdT-mediated dUTP Nick end Labeling) assay was used to 
calculate apoptosis in the testes and is expressed as the number of TUNEL-positive germ 
cells per 100 Sertoli cell nuclei (Heninger et al, 2006). 
Hormone assays 
 Circulating serum levels of T, EEL, LH, FSH and inhibin concentrations were 
determined by radioimmunoassay (RIA) (Courtesy of J. F. Roser, Department of Animal 
Science, University of California, Davis, CA) for the ten mature horses used in this 
study.  Heparinized blood samples were collected from the jugular vein once every hour 
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for four hours prior to sedation and castration.  Plasma was isolated by centrifugation at 
10,000 x g for 10 minutes and samples were pooled within stallions prior to conducting 
assay. 
Cloning StAR cDNA 
 An equine probe for StAR protein mRNA was generated by cloning cDNA from 
the horse testes as previously described (Ing et al, 1996).  PolyA+ RNA (200 ng) was 
reverse transcribed at 42°C with Superscript II (Life Technologies, Newark, NJ) and 
random hexamer primers.  PCR was performed sequentially with two sets of primers 
designed to human cDNA sequence with the set of primers used for the second 
amplification nested inside the first.  Outside primers were 5‟-GCTCTTGGGCAGCCA 
CCCCT-3‟, 5‟-AGTGATGAGTAAAGTGGTCCC-3‟ and inside primers were 5‟-
CCAAGCCTTCATTAACCCTCACTAAAGGGAGAGAGGTCGATGCTGAGTAGCC
-3‟, 5‟-CAGAGATGCATAATACGACTCACTATAGGGAGAAGATGTGGGCAAGG 
TGTTCCG-3‟.  PCR with outside primers and reverse-transcribed testis cDNA (20 
cycles) was used as template for PCR with the inside primers (30 cycles).  The cDNA 
was cloned into the PCR2.1 vector (Invitrogen, Austin, TX), and multiple clones were 
sequenced.  The horse StAR protein sequence is in GenBank (accession number 
AY349170).  The cDNA template for PDE3B antisense cRNA was a linearized plasmid 
previously described (Ing et al, 2004). 
In situ hybridization 
 The mRNAs for PDE3B and StAR protein were localized on serial cross sections 
of testes by in situ hybridization to quantify expression as previously described (Ing et 
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al, 1997).  Paraffin-embedded sections (5 µm) were mounted on glass Superfrost plus 
slides (VWR Scientific, West Chester, PA, USA) and sections hybridized at 42°C for 16 
h with radiolabeled sense (negative control) and antisense PDE3B or StAR protein 
cRNA probes generated using in vitro transcription with α [35S]-UTP (1250 Ci/mmol, 
New England Nuclear, Boston, MA, USA).  A plasmid containing human PDE3B cDNA 
was restricted with BamH1 and transcribed with T7 or T3 RNA polymerase for antisense 
and sense cRNAs.  Antisense and sense horse StAR protein cRNAs were produced from 
PCR products with T3 and T7 RNA polymerases, respectively.  Following hybridization, 
washing, and ribonuclease A digestion, slides were coated with photographic emulsion 
(Eastman Kodak, Rochester, NY, USA) and allowed to expose for 28 d.  After emulsion 
development, cell nuclei were counterstained with 0.1% toluidine blue.  Images were 
visualized using a Zeiss Axioplan 2 Microscope (Gottingen, Germany) and digital 
images were captured with a Nikon Alpha Photo Digital Imager and processed with 
Adobe Photoshop (Adobe Systems, Seattle, WA, USA). 
Quantification of mRNA 
 Testicular expression of PDE3B and StAR protein mRNA was quantified for 
each stallion testis by measuring mean silver grain density (hybridization signal) on 
individual slides.  Three randomly selected regions proximal to the central vein of each 
histological testis section were observed and captured under brightfield and darkfield 
microscopy.  Five round seminiferous tubules from each of the three regions (n=15) 
were evaluated for PDE3B mRNA hybridization signal strength for each horse.  StAR 
protein mRNA signal was evaluated similarly except the interstitial space where Leydig 
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cells reside was used for quantification. The image processing and analysis program, 
Scion Image Software (National Institutes of Health, Bethesda, MD, USA), was used for 
both PDE3B and StAR protein mRNA measurements.  Scion Image was used to 
measure the mean silver grain density in selected regions based on a scale of 0 (white; 
representing hybridization signal) to 255 (black; representing a lack of hybridization 
signal) in darkfield images.  Grayscale, pixel inversion and threshold parameters within 
the program were set prior to measurement analysis.  Mean silver grain density was 
recorded for each testis by manually outlining round seminiferous tubules or interstitial 
space.  Data were normalized by subtracting mean silver grain density acquired from 
sense control sections from antisense hybridized sections and by accounting for area of 
each measurement. 
Statistics 
 Data for in situ hybridization quantification were analyzed by one-way ANOVA 
with means separated post hoc using Tukey‟s Honest Significant Difference (HSD) 
(SPSS
© 
Inc., Chicago, IL, USA, 2001) and reported as mean silver grain density values 
in arbitrary units with standard deviation (SD) or standard error (SEM) where 
appropriate.  Kendall‟s tau-b correlation coefficients were calculated for the analysis of 
relationships between individual horse testis, semen and hormone parameters, and either 
PDE3B or StAR protein mRNA mean silver grain density values.  P values less than 
0.05 indicated a significant difference. 
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Results 
In situ hybridization identifies differences in gene expression for PDE3B and StAR 
protein mRNAs in testes of mature stallions 
 In situ hybridization was conducted on testicular tissues from ten mature stallions 
to determine differences in expression of PDE3B and StAR protein genes.  Expression 
differences were apparent based on hybridization signals captured on images for both 
PDE3B and StAR protein mRNA (Fig. 4 and Fig 5, respectively).  Distinct differences in 
signal intensity and transcript localization can be visualized in both the brightfield and 
darkfield views among the stallions.  Figure 4 shows a noticeable difference in the 
expression of the mRNA for the PDE3B gene between the stallion with the highest 
intensity of signal (stallion 1957, panels A and B) and the stallion with the lowest 
intensity of signal (stallion Peppy, panels S and T).  In addition, the PDE3B mRNA 
signal is specifically localized within the seminiferous tubules. 
 Likewise, Fig. 5 demonstrates gene expression differences among individual 
stallions for StAR protein mRNA.  StAR protein has been found previously in the 
testicular Leydig cells, which are located in the interstitial space outside of the 
seminiferous tubules (Pollack et al, 1997; Kotula et al, 2001).  Our data confirm these 
findings and demonstrates that hybridization signal intensity is different among 
individual stallions.  One notable difference among hybridization signals of StAR 
protein was the total area occupied by the interstitial space.  Stallions with higher hybrid- 
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Figure 4.  In situ hybridization reveals mean silver grain density differences of 
phosphodiesterase 3B (PDE3B) gene expression in seminiferous tubules of horse testis.  Testis 
cross-sections were fixed with paraformaldehyde, mounted onto glass slides and hybridized with 
a PDE3B antisense cRNA 
35
S-labeled probe.  Cell nuclei were stained with 1% toluidine blue 
following autoradiography.  Black silver grains on the brightfield images (panels A, C, E, G, I, 
K, M, O, Q, and S) and small silver grains displayed in white on darkfield images (panels B, D, 
F, H, J, L, N, P, R, and T) show representative images of in situ hybridization signals of PDE3B 
mRNA for ten horses.  Non-specific binding to sense PDE3B cRNA (a negative control) is 
shown in panels U and V.  The bar in panel U indicates 100 µm. 
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Figure 5.  In situ hybridization shows differences in hybridization signal of steroidogenic acute 
regulatory protein (StAR) mRNA in the interstitial space of horse testis.  Silver grain densities 
demonstrated on brightfield and darkfield slides are shown.  Hybridization signal for StAR 
protein mRNA are localized in the interstitial space of the testis tissue.  A noticeable decrease in 
the amount of signal (lack of white grains in darkfield panels) is observable between the stallion 
with the highest signal intensity (stallion 1957, panel B) and the stallion with the lowest signal 
intensity (stallion Peppy, panel T).  Panels U and V represent sense images (negative control).  
The bar in panel U indicates 100 µm. 
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ization signal not only demonstrated a more intense signal suggesting more transcripts 
but the total signal area appeared to be greater than that observed for stallions with lower 
amounts of signal.  
Quantitative in situ hybridization analysis reveals significant differences between horses 
for PDE3B and StAR 
 Mean silver grain density values (hybridization signal) from the in situ 
hybridization experiments were quantified by Scion image software and reported in 
arbitrary units (Table 3).  One-way ANOVA was computed comparing the average 
hybridization signals for PDE3B among the ten mature stallions.  A significant 
difference was found among the stallions for PDE3B (P < 0.05).  Tukey‟s HSD was used 
to determine the nature of the differences between the stallions.  The stallions (1957, 
1955 and 1861) with the highest observed intensity of PDE3B mRNA were significantly 
(m = 8.70, sd = 2.07; m = 8.66, sd = 1.01; m = 8.56, sd = 1.38; respectively) higher and 
demonstrated over a two-fold increase in hybridization signal compared to the stallion 
(Peppy) with the weakest signal.  Peppy (m = 3.50, sd = 0.77) was significantly lower in 
signal intensity than all other stallions.  Similarly, quantitative data summarizing StAR 
protein is reported in Table 4.  A significant difference (P < .05) was found among the 
stallions.  This analysis revealed close to a three-fold difference in hybridization signal 
between the stallions (1957, 75 and 1906)) with the highest and the stallions (Peppy and 
Lucky) with the lowest values.  
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Table 3.  Quantitative in situ hybridization results of phosphodiesterase 3B (PDE3B) 
mRNA and seminiferous tubule area in the testis of ten mature stallions.  PDE3B mRNA 
data is expressed as mean silver grain density ± S.D. in arbitrary units (AU).  The Area 
of seminiferous tubules is expressed as mean values ± S.D. 
Stallions               PDE3B mRNA (AU) Area of Seminiferous Tubules (AU) 
 1957 8.70±2.07
a
  5.02±0.83
a
  
 1955 8.66±1.01
a
  5.09±0.51
a
  
 1861 8.56±1.38
a, b
  4.64±0.76
a
  
 1959 7.47±1.18
a, b
  6.07±0.96
b
  
 1906 7.07±1.66
b, c
  6.23±1.02
b
  
 75 5.85±0.92
c, d
  5.35±0.40
a, b
  
 Arab 5.70±1.53
c, d
  6.30±1.40
b
  
 1859 5.44±1.20
d
  4.81±0.47
a
  
 Lucky 5.18±1.13
d
  5.59±0.78
a, b
  
 Peppy* 3.50±0.77
e
  4.80±0.56
a
  
* Classified as having reduced quality semen (<23% PMS and < 39% MNS).  All other 
 stallions were classified as normal (≥60% PMS and ≥ 55% MNS) semen quality. 
a-e  
Different superscripts within a column differ (P<0.05). 
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Table 4.  Quantitative in situ hybridization results of steroidogenic acute regulatory 
protein (StAR) mRNA and measured interstitial space area in the testis of ten mature 
stallions.  Data is expressed as mean silver grain density ± S.D. for StAR protein mRNA 
and mean ± S.D. interstitial space area in arbitrary units (AU). 
Stallions                  StAR mRNA (AU)                 Area of Interstitial Space (AU) 
 1957 14.53±1.93
a
 2.88±0.31
a, b
 
 75 14.49±2.69
a
 3.00±0.40
a, b 
 1906 14.41±2.16
a
 3.05±0.39
a 
 Arab 12.44±2.99
a, b 
2.86±0.59
a, b 
 1959 11.48±2.20
b, c
 2.69±0.40
a, b 
 1861 9.68±2.35
c, d
 2.68±0.37
a, b 
 1859 8.40±2.01
d, e
 3.00±0.63
a, b 
 1955 7.59±1.23
e, f
 3.01±0.35
a 
 Lucky 6.53±1.74
e, f
 2.51±0.42
b 
 Peppy* 5.40±1.23
f
 1.94±0.11
c 
* Classified as having reduced quality semen (<23% PMS and < 39% MNS).  All 
 other stallions were classified as normal (≥60% PMS and ≥ 55% MNS) semen 
 quality. 
a-f  
Different superscripts within a column differ (P<0.05). 
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Correlations of PDE3B and StAR protein mRNA 
 The Kendall‟s tau-b correlation coefficient was calculated to determine the 
relationship between the gene expression values of PDE3B and StAR protein mRNA to 
testis, semen, and hormone levels of the ten mature stallions previously described.  Mean 
(± SEM) values for parenchyma weight (g), DSP per gram, DSP per testis, DSP per 
horse, DSO, apoptosis rate, and circulating concentrations of T, EEL, LH, FSH and 
inhibin are summarized in Table 5 along with the calculated Kendall‟s tau-b correlation 
coefficient values for PDE3B and StAR protein mRNA (see Appendix B for individual 
stallion data).  No significant relationships were found between PDE3B and testis, 
semen, or endocrine characteristics.  However, a moderately positive correlation (r = 
.556) that was significant (p = .025) was found between StAR protein mRNA and 
testosterone. Although no other significant relationships were found for StAR protein 
mRNA, several other relationships were significant between gonadal characteristics and 
circulating hormone levels.  Testosterone was positively correlated with parenchyma 
weight (r = .600, p = .015), DSP per testis (r = .555, p = .025), DSO (r = .555, p = .037) 
and negatively correlated with FSH (r = -.510, p = .040).  Estradiol 17β was positively 
correlated with parenchyma weight (r = .510, p = .040) and negatively correlated with 
FSH (r = -.510, p = .040).  Inhibin was positively correlated with parenchyma weight (r 
= .600, p = .016) and DSP per testis (r = .556, p = .025).  Daily sperm per testis was 
positively correlated with parenchyma weight (r = .600, p = .016) and DSP per horse (r 
= .722, p = .007).  Significant negative correlations were found between apoptotic rate 
 Table 5.  Kendall‟s tau-b coefficients describing the relationship of mean values (± SEM) of equine testis, semen parameters, 
and circulating hormone concentrations to mean silver grain densities of phosphodiesterase 3B (PDE3B) and steroidogenic 
acute regulatory protein  (StAR) mRNA quantified by in situ hybridization. 
Gonadal characteristics  
and circulating hormone  PDE3B Significance* StAR Significance* 
concentrations n Mean ± SEM (r) (2-tailed) (r) (2-tailed) 
Testis and Semen Parameters 
 Parenchyma Weight (g) 10 197.19±11.05 0.333 0.180 0.333 0.180 
 Daily Sperm Production (10
6
) 
  Per gram 10 15.59±0.64 -0.244 0.325 0.022 0.929 
 Per testis  10 3062±178 0.200 0.421 0.289 0.245 
 Per horse 9
†
 6228±375 -0.278 0.297 0.056 0.835 
 Daily Sperm Output (10
6
) 9
†
 6356±472 -0.333 0.211 0.222 0.404 
 Apoptotic Rate 9
††
 7.47±1.13 0.167 0.532 -0.167 0.532 
Endocrine Profile 
 Testosterone (ng/ml) 10 1.40±0.16 0.200 0.421 0.556 0.025* 
 Estradiol 17β (pg/ml) 10 51.24±2.91 0.200 0.421 0.378 0.128 
 LH (ng/ml)  10 6.46±0.56 0.289 0.245 -0.067 0.788 
 FSH (ng/ml) 10 4.25±0.51 0.111 0.655 -0.160 0.531 
 Inhibin (ng/ml) 10 3.72±0.31 0.289 0.245 0.200 0.421 
* Correlation is significant at the 0.05 level (2 tailed). 
†
 Data for stallion „Peppy‟ was not calculated. 
†† Data for stallion „Lucky‟ was not calculated. 
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and testosterone and inhibin (r = -.611, p = .022), DSP per testis (r = -.611, p = .022), 
DSP per horse (r = -.643, p = .026) and DSO (r = -.714, p = .013). 
Gene expression changes in the testes of unilateral cryptorchid stallions 
 Expression of PDE3B and StAR protein genes was assessed by in situ 
hybridization and were studied in one-year-old (n = 3) and three-year-old (n = 3) 
unilateral cryptorchid stallion testes.  PDE3B hybridization signal was highest in the 
three-year-old descended testes (Fig. 6; panel F).  There were no observable differences 
in PDE3B gene expression between the three-year-old retained (panels G and H), one-
year-old descended (panels A and B) or one-year-old retained (panels C and D) testes for 
PDE3B.  All had very low hybridization signals.  Figure 7 shows the in situ 
hybridization results for StAR protein mRNA in the testes of unilateral cryptorchid 
stallions.  Differences are observed between the one-year-old representatives (panels B 
and D) where the abdominally retained testes demonstrate a stronger hybridization signal 
than the descended testes.  As expected, the strongest StAR protein mRNA signals were 
found in the descended testes of the three-year-old horses (panels E and F).  These 
appear to have intensities that are at least 2X greater than those in the retained testes of 
the three-year-olds (panels G and H).  The weakest signal amongst the four groups is 
seen in the descended testes of the one-year-old horses (panels A and B). 
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Figure 6.  In situ hybridization of phosphodiesterase 3B (PDE3B) mRNA demonstrates 
differences in gene expression in seminiferous tubules of retained and descended testis of one-
year-old and three-year-old unilateral cryptorchid horses.  Matching brightfield (left column) and 
darkfield (right column) images show one-year-old descended testis (panels A and B), one-year-
old retained testis (panels C and D), three-year-old descended testis (panels E and F) and three-
year-old retained testis (panels G and H).  Negative control sense PDE3B probe is shown in 
panels I and J.  A difference in signal strength is visualized in the three-year-old descended 
image (panel F) compared to all others.  The bar in panel I represents 50 µm. 
 
74 
 
 
Figure 7.  In situ hybridization reveals greater signal intensity for steroidogenic acute regulatory 
protein (StAR) mRNA in three-year-old descended horse testis compared to retained and 
descended testis of one-year-old and three-year-old retained testis representatives.  Adjacent 
panels represent matching brightfield and darkfield images as one-year-old descended testis (A 
and B), one-year-old retained testis (C and D); three-year-old descended testis (E and F), three-
year-old retained testis (G and H).  A sense StAR RNA probe was uses as a negative control 
(panels I and J).  Bar in panel I represent 50 µm. 
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Quantification of PDE3B and StAR protein mRNA reveals significant differences in 
unilateral cryptorchid stallion testes  
 In order to more thoroughly investigate the observed differences found in the 
testes of unilateral cryptorchid stallions for PDE3B and StAR protein mRNAs, we 
quantified the hybridization signals and compared the differences by one-way ANOVA 
(Fig 8).  A significant increase (P < 0.05) in the expression of the PDE3B gene (Fig. 8, 
A) was found in the three-year-old descended testes (m = 2.68, sd = 0.55) compared to 
all of the others.  These data for PDE3B are consistent with our previous work and 
suggest that an increase in transcription of PDE3B mRNA occurs in spermatogenically 
active stallions (Ing et al, 2004). 
 Significant differences (P < 0.05) were also found for StAR protein gene 
expression (Fig. 8, B).  The three-year-old descended testes had the highest hybridization 
signal strength (m = 16.78, sd = 5.59) and was significantly different from the three-
year-old retained testes (m = 9.15, sd = 3.87).  However, this trend was reversed in the 
younger stallions where the hybridization signal in the retained testes (m = 10.20, sd = 
2.91) was significantly higher than the signal found in the descended testes (m = 7.22, sd 
= 2.56).  No difference was found between the three-year-old retained testes and either 
of the one-year-old groups. 
Discussion 
 In this study, in situ hybridization revealed differences in PDE3B gene 
expression in testes from ten mature stallions.  PDE3B gene expression was highly 
specific to cells inside the seminiferous tubules and  these findings complement previous 
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Figure 8.  Quantification of phosphodiesterase 3B (PDE3B) (A) and steroidogenic acute 
regulatory protein (StAR) (B) transcripts in unilateral cryptorchid one-year-old (n=3) and three-
year-old (n=3) stallion testes.  Results are presented as mRNA levels calculated as mean silver 
grain densities from slides following in situ hybridization in arbitrary units. Background signal 
(pixel densities on sections probed with sense cRNAs) was subtracted from raw data and 
normalized to area of seminiferous tubules for PDE3B or interstitial space for StAR protein.  
Error bars represent standard deviations.  Means with different superscripts differ (P<0.05). 
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work (Reinhart et al, 1995; Ing et al, 2004).  However, this PDE3B gene expression was 
not localized to all spermatogenic cell types.  This suggests that PDE3B is specific to 
certain germ cells, probably spermatocytes and more mature germ cells, because signal 
is not apparent in early spermatogonia cells that line the basement membrane.  Sertoli 
cells cannot be excluded as possible candidates for producing PDE3B transcripts but our 
evidence suggests that they are not the dominant cell type for this mRNA because the 
hybridization signal does not span the entire area of both the basal and ad luminal 
compartments of the seminiferous tubule.  Interestingly, strong hybridization signal for 
PDE3B (Fig 4, panels A and B) is visible in small ring-like, or circular patterns 
throughout the tubule.  It was apparent that some tubules had less signal intensity than 
other adjacent tubules (not shown) which provides further evidence that the transcription 
of this gene may be specific to certain germ cells in the testis.  It would be interesting in 
future studies to compare PDE3B signal strength in the stages of the seminiferous 
epithelium and to localize the signal to specific cell types.  Significant differences in the 
amount of PDE3B mRNA were discovered among the 10 mature horses as initially 
hypothesized (Table 3).  Of interest was the one horse categorized as having reduced 
quality semen also had the lowest concentration of PDE3B mRNA.  In addition, the 
same horse also had the lowest value for parenchyma weight, DSP per testis and 
circulating concentrations of T, EEL, and inhibin and demonstrated one of the highest 
values for apoptotic rate compared to the other horses. 
 No significant correlations were found for PDE3B mRNA.  Interestingly, there 
was a moderately negative, but not significant, relationship between PDE3B mRNA and 
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DSO (r = -.333, p = .211).  This inverse relationship reveals that the lower amount of 
PDE3B mRNA may be related to horses with higher DSO and contradicts our original 
hypothesis that PDE3B would be positively correlated to DSO in stallions.  In addition, 
the correlation coefficient for tubule area and DSO was close to a zero value (r = -.056, p 
= .835) and provides strong evidence that tubule area did not affect DSO in these 
stallions.  However, additional work is needed to evaluate the relationship between the 
PDE3B gene and DSO as DSO, along with daily sperm production per horse and DSP 
per gram and was not calculated for the horse (Peppy) with reduced quality semen. 
 As predicted, in situ hybridization plainly showed gene expression differences 
among the mature stallion testes for StAR protein mRNA hybridization signal.  As 
expected, the horse (Peppy) with poor quality semen and low circulating T also had the 
lowest signal intensity for StAR protein mRNA (Fig 5).  Quantitation of StAR protein 
mRNA revealed differences between the highest and lowest values and approached a 
three-fold change in gene expression.  Also, the method used to calculate gene 
expression for StAR protein mRNA demonstrated a difference between two horses 
(1861 and Peppy), where stallion „1861‟ had a significantly higher mean silver grain 
density than stallion „Peppy‟.  StAR protein gene in these two horses was previously 
found in earlier experiments to be differentially expressed using microarray technology.  
These same results in different experiments help validate the use of the Scion Image 
Software program as a useful tool in investigating gene expression differences. 
 The number of Leydig cells per area was not evaluated in this study and would 
be valuable in future investigations.  However, we can hypothesize that higher levels of 
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StAR protein mRNA signal corresponds to an increased density of Leydig cells in the 
interstitial areas in the testes.  The moderately positive correlation found between StAR 
protein mRNA and testosterone indicate a significant relationship between the two 
variables and suggest that stallions with greater expression of the StAR protein gene tend 
to have a higher circulating amount of testosterone.  To our knowledge, this is the first 
time this relationship has been reported in stallions or any other species.  Also, our data 
for StAR protein mRNA and LH opposes other work that demonstrates an increase in 
StAR protein expression when ovine tissue was stimulated with LH (Price et al, 2000).  
One possible explanation for this discrepancy could be in the manner in which blood 
samples were taken to establish the endocrine profile.  In this data set, one horse had a 
pooled mean value for LH three times higher than the mean value for all other horses.  
Additionally, it is possible that pooled samples did not adequately depict the dynamics 
of the hormone profile for each stallion. 
 Concentrations and localization of PDE3B and StAR protein mRNAs were 
evaluated in cryptorchid stallion testes.  Gene expression differences were compared 
between one-year-old and three-year-old unilateral cryptorchid stallions and between 
descended and retained testes.  An observable difference found by in situ hybridization 
was that PDE3B mRNA was only present in spermatogenically active tissue (the 
descended testes of the three-year-old post-pubertal horses).  This agrees with our 
previous work (Ing et al, 2004).  It has been reported that development of the germinal 
epithelium in retained testes is arrested and, therefore, the retained testes are not 
spermatogenically active (Coryn et al, 1981).  Later studies described differences 
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between abdominally retained and inguinal retained testes where abdominal testis 
development did not proceed beyond B spermatogonia (equivalent to spermatogenesis in 
a four-month-old foal) and inguinal testis demonstrated some development up to early 
spermatocytes (equivalent to spermatogenesis in a 12-month-old foal) (Arighi et al, 
1987; Al-Bagdadi et al, 1991).  In this study, inguinal or abdominal retention was not 
documented at the time of testes harvest.  Additional studies comparing the differences 
among descended, inguinally retained and abdominally retained stallion testes could 
provide further insight into the steroid hormone biosynthesis and intercellular 
communication in the equine testes. 
 Evaluation of StAR protein mRNA in the cryptorchids revealed interesting 
differences between the two age groups.  In the three-year-olds, stronger hybridization 
signals were evident in the descended testes, while one-year-olds revealed stronger 
signal in the retained testes.  To our knowledge, these age differences for StAR protein 
mRNA expression in unilateral cryptorchids are reported here for the first time.  It may 
be possible to explain these differences solely based on Leydig cell numbers in the 
interstitial space, however, controversies exist about Leydig cell populations in unilateral 
cryptorchids and conclusive evidence has not been reported.  Some authors report no 
differences between Leydig cell numbers in retained and descended testes of human 
patients (Sirvent et al, 1989).  Others report that androgen production increases in tissues 
from unilateral cryptorchid rat testis when treated with LH compared to the contralateral 
testis and descended testes of normal animals (Jansz and Pomerantz, 1986).  This study 
suggests that Leydig cell numbers in cryptorchid tissues may be elevated; however, 
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Leydig cell numbers were not reported.  Clemmons (1995) indicated that there was an 
increase in Leydig cell numbers in spermatogenically inactive tissue (dark parenchyma) 
compared to spermatogenically active tissue (light parenchyma) of stallion testis.  This 
increase was most likely due to smaller seminiferous tubules in the dark parenchyma 
which allowed for greater Leydig cell concentrations in the interstitial space.  As the 
testis became spermatogenically active, seminiferous tubules increased in circumference 
and the total area of interstitial space decreased; therefore, decreasing the density of the 
Leydig cells.  Johnson and Neaves (1981) also describe an increase in Leydig cell 
numbers as stallions increase in age; however, neither of the later two studies 
investigated cryptorchid testis. 
 In conclusion, we have shown gene expression changes by in situ hybridization 
in testes from mature normal and immature and mature cryptorchid stallions for 
concentrations of both PDE3B and StAR protein mRNAs.  These results indicate that 
these genes are regulated in the testes.  To date, most of the work with PDE3B has been 
focused on investigating its function and usefulness as a target for various drugs in 
adipose tissue, liver, pancreas and cardiovascular tissue, but not in the testis (Shakur et 
al, 2001; Bender and Beavo, 2006).  Identifying the specific germ cells that transcribe 
the PDE3B gene requires additional investigation and would be beneficial in 
understanding the role of PDE3B in gamete development.  Additionally, the findings of 
increased levels of StAR protein mRNA expression in three-year-old unilateral 
cryptorchid testes compared to one-year-old unilateral cryptorchid testes and that 
retained testes of one-year-old cryptorchids demonstrated significantly higher signal 
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intensity for StAR protein mRNA compared to one-year-old descended testes in this 
study may help us to understand the development of steroidogenesis. 
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CHAPTER V 
IN VITRO CULTURE OF PRECISION-CUT TESTICULAR TISSUE AS A 
NOVEL TOOL FOR THE STUDY OF RESPONSES TO LH* 
Introduction 
 Investigating the molecular functions of the testis has been challenging due to the 
many cytological interactions that occur within the organ.  Development of in vitro 
culture techniques that support cellular survival and spermatogenesis will aid in our 
understanding of this complex tissue.  Various methods have been used to elucidate 
regulatory mechanisms within the testis such as cell and tissue culture systems, but they 
have not been entirely successful (Staub 2001; Parks et al, 2003).  Theoretically, organ 
culture systems are advantageous due to their controlled environments and the fact that 
they allow typical cellular interactions to proceed.  However, their use has proven 
problematic due to an inability to maintain cell viability for extended periods of time and 
the need to supply uniform access of medium and gas exchange to the tissues (Orth et al, 
1998). 
 Precision-cut tissue slice (PCTS) in vitro culture has emerged as a possible 
system to evaluate testicular functions.  The precision-cut technique utilizes slivers of 
whole organs placed on wire mesh grids and incubated in small culture vessels 
containing  medium  and  gases   (Smith et al, 1985).   This  organ  culture  approach  has  
___________ 
*This material has been published in In Vitro Cellular and Developmental Biology – Animal, 
1071-2690 November 2009, 10.1007/s11626-009-9242-1, the only accredited archive of the 
content that has been certified and accepted after peer review.  Copyright and all rights therein 
are retained by Society for In Vitro Biology.  (www.sivb.org). 
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provided a valuable means for investigation due to the reproducibility of mechanical 
tissue slicing, the ability to use organ slices that mimic tissues in vivo, and the 
maintenance of tissue architecture (Parrish et al, 1995).  The PCTS in vitro culture 
system has been used successfully with several tissues such as liver, kidney, lung and 
heart (Parrish et al, 1995; Turney et al, 1999).  Furthermore, PCTS has been used to 
challenge tissues in vitro from several animal models. These studies have included in 
vitro challenges with various compounds on mouse liver slices, rabbit renal slices and 
human prostate slices (Parrish et al, 1999b; Turney et al, 1999; Schmelz et al, 2001; 
Parrish et al, 2002).  Although similar systems (Steinberger and Klinefelter, 1993; Orth 
et al, 1998) have been used to investigate somatic/germ cell interactions and gene 
expression in culture, to our knowledge this is the first report describing the use of PCTS 
with any equine tissue. 
  The purpose of the present study was to validate a short-term in vitro culture 
system using PCTS from stallion testes.  Our approach was to challenge the equine 
testicular tissue with ovine luteinizing hormone (oLH) and measure the effects on 1) 
steroid hormone production and release into the medium and 2) mRNA gene expression.  
Following the 6-h in vitro culture, medium was collected and evaluated for testosterone 
(T) and estradiol-17β (E2) concentrations.  Additionally, the relative expression of 
steroidogenic acute regulatory protein (StAR protein), phosphodiesterase 3B (PDE3B) 
and outer dense fiber of sperm tails 2 (ODF2) mRNAs were quantitated.  These genes 
were selected for analysis because of their past association with either initiation of 
spermatogenesis (Ing et al, 2004) or fertility status (not shown).  Studies have also 
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shown that LH-induced StAR protein increases steroidogenesis in MA-10 mouse Leydig 
cells and that cells in culture have maintained viability based on production and release 
of T and E2 into the medium (Clark et al, 1994; Manna et al, 2004). 
 In the current experiments, viability of the tissue during culture was assessed by 
evaluating histological integrity (histoarchitecture), measuring the release of lactate 
dehydrogenase (LDH), an intracellular enzyme, into the medium and steroidogenic 
activity (release of T and E2 into the medium).  We hypothesized that the administration 
of increasing doses of oLH would result in an increase in both T and E2 production and 
secretion.  Additionally, we hypothesized that mRNA levels of StAR protein would 
increase with increasing doses of oLH and that there would not be an observable 
increase in expression of PDE3B or ODF2 genes. 
 This study was designed to demonstrate that PCTS can be an effective tool for 
investigation of testicular tissue in stallions.  Validation of this in vitro system will 
facilitate studies of mechanisms which regulate expression of genes that are involved in 
testis functions including spermatogenesis. Ultimately this system could be used to 
elucidate factors that impair or augment male fertility in all mammalian species. 
Materials and Methods 
Animals 
 Whole testes (84-133 gm, each) from three immature light breed stallions were 
collected post-mortem from a commercial abattoir.  Immediately following organ 
harvest, testes were placed on ice and transported 2.5 h to Texas A&M University where 
they were weighed and decapsulated while chilled on ice.   
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Precision-cut tissue slices 
 Testicular slices were initially prepared by removing the distal ends of each testis 
and punching cylindrical cores (8 mm diameter) of tissue proximal to the central vein.  
Individual testicular slices were cut using a Brendel/Vitron Slicer (Tucson, AZ, USA) 
and held in oxygenated Krebs-Bicarbonate slicing buffer (pH 7.4, 4°C, O2:CO2, 95:5) 
following the procedures described by (Parrish et al, 1995).  The overall mean slice 
weight and thickness were 13.85 ± 0.20 mg and 515.00 ± 2.33 µm, respectively.  Fresh 
slices for incubation were aligned on titanium-mesh inserts (four slices per insert) and 
placed into scintillation vials with 1.7 ml of Dulbecco‟s Modified Eagles Media 
(DMEM) supplemented with 10% charcoal-stripped, heat-inactivated fetal bovine serum 
(FBS), glutamine (200 mM), penicillin/streptomycin (5,000 units/ml) and gentamycin 
(50 µg/ml) in an atmosphere of 95:5 O2/CO2.  This system uses roller culture, where the 
vials rotate in the incubator and expose the slice surfaces to medium and gas throughout 
the time course of incubation.  The roller system reduced tissue necrosis when compared 
with alternate incubation systems (Parrish et al, 1995). 
 Slice samples were pre-incubated in medium without oLH for 1 h at 32°C and 
fresh medium was replaced prior to challenge to allow cells to normalize following 
mechanical stress.  Treatments consisted of medium containing 0, 5, 50 or 500 ng/ml of 
ovine luteinizing hormone (oLH; characterized by Dr. Parlow, NIADDK-oLH-25, 
purified from ovine pituitary glands, biological potency of 2.3 U/mg) to stimulate steroid 
hormone (T or E2) production and release.  Each testis was evaluated in triplicate 
cultures at each dose.  Tissue slices were incubated with oLH for 6 h at 32°C.  At the 
87 
 
conclusion of the incubation period, slices were removed from scintillation vials and 
random slices per treatment were weighed.  The remaining slices were fixed in 4% 
paraformaldehyde in phosphate-buffered saline (PBS), (pH 7.2) and embedded in 
Paraplast (Fisher Scientific, Houston, TX, USA).  Slice thickness was measured after 
transverse cross-sectioning following paraffin embedding. 
Cloning of StAR cDNA from horse testis 
 cDNA was cloned from the horse to make a high-specificity probe for StAR 
mRNA similar to cloning previously described (Ing et al, 1996).  PolyA+ RNA (200 ng) 
from mature stallion testis was reverse transcribed at 42°C with Superscript II (Life 
Technologies, Carlsbad, CA, USA) and random hexamer primers.  PCR was performed 
sequentially with two sets of primers designed to human cDNA sequence with the set of 
primers used for the second amplification nested inside the first.  “Outside” primers were 
5‟-GCTCTTGGGCAGCCACCCCT-3‟, 5‟-AGTGATGAGTAAAGTGGTCCC-3‟ and 
“inside” primers were 5‟-CCAAGCCTTCATTAACCCTCACTAAAGGGAGAGAGGT 
CGATGCTGAGTAGCC-3‟,5‟-CAGAGATGCATAATACGACTCACTATAGGGAGA 
AGATGTGGGCAAGGTGTCCG-3‟ for StAR protein cDNA.  Inside primers had T7 or 
T3 promoter sequences on sense and antisense primers, respectively.  The cDNA was 
cloned into the PCR2.1 vector (TA Cloning Kit, Invitrogen, Carlsbad, CA, USA), and 
multiple independent clones were sequenced.  The horse StAR cDNA sequence was 
submitted to GenBank (accession number AY349170). 
In situ hybridization 
 The mRNAs for StAR, PDE3B and ODF2 were localized by in situ hybridization 
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on serial cross sections of the equine testis slices generated from PCTS following the 
procedures of Ing et al. (1997).  Paraffin-embedded sections were cut to a thickness of 5 
µm and mounted on Superfrost Plus slides (VWR Scientific, West Chester, PA, USA).  
Tissue sections were hybridized at 42°C for 16 h with radiolabeled sense (control) and 
antisense cRNA probes generated by in vitro transcription with α [35S]-UTP (1250 
Ci/mmol, New England Nuclear, Boston, MA, USA).  Antisense and sense horse StAR 
cRNAs were produced from PCR products with T3 and T7 RNA polymerases, 
respectively.  Human PDE3B and rat ODF2 cDNA-bearing plasmids were restricted 
within the cDNAs with BamH1 for PDE3B and Nco1 for ODF2 and transcribed with 
either T3 or T7 RNA polymerase, respectively, as previously described (Ing et al, 2004).  
Following hybridization, washing, and ribonuclease A digestion, slides were coated with 
photographic emulsion (Eastman Kodak, Rochester, NY, USA). After 28 d, slides were 
developed and cells were counterstained with 0.1% toluidine blue.  Brightfield and 
darkfield images were visualized with a Zeiss Axioplan 2 Microscope (Carl Zeiss, 
Gottingen, Germany) mounted with an Axioplan high-resolution digital camera.  Images 
were captured with Axiovision 3.0 software. 
Quantification of mRNA signal 
 Testicular expression of StAR, PDE3B and ODF2 mRNA was quantified for 
each stallion by measuring hybridization signal strength (silver grains in darkfield 
measured by pixel density) on individual slides.  Ten randomly selected round 
seminiferous tubules from representative slices were used for quantification of PDE3B 
and ODF2 mRNA.  StAR mRNA signal was evaluated similarly except the interstitial 
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space was used for quantification.  Each field was captured under brightfield and 
darkfield microscopy at 400 X.  Scion Image Software (National Institutes of Health, 
Bethesda, MD, USA) was used to calculate pixel values in selected regions based on a 
scale of 0 (white; representing hybridization signal) to 255 (black; representing a lack of 
silver grains).  Grayscale, pixel inversion and threshold parameters within the program 
were set prior to measurement analysis.  Mean silver grain density was recorded for each 
testis by manually outlining round seminiferous tubules or interstitial space within the 
program.  Data were normalized by subtracting background from control sections 
hybridized to sense cRNA. 
Radioimmunoassay 
 At the conclusion of the incubation period, spent medium was collected from 
each sample, centrifuged to pellet cell debris and stored at -20°C (Catania et al, 2003).  
All spent medium samples were analyzed for T and E2 using radioimmunoassay (RIA).  
For T determination, 250 µl of medium were extracted with 5 ml diethyl ether (EM 
Science, Cincinnati, OH, USA).  Each sample was analyzed in duplicate and corrected 
for extraction efficiency of 71%.  Standards were prepared by reconstitution in 500 µl of 
phosphate-buffered saline-gel buffer (PBSG) with known amounts of 
3
H-testosterone 
(Perkin Elmer-New England Nuclear, Inc., Boston, MA, USA) and 100 µl of T 
(Colorado State University) ranging from 3.9 pg/ml to 8,000 pg/ml.  Pooled bull plasma 
was used to calculate the intra-assay coefficient of variation (CV) and was 2.97%.    
 For E2 determination, samples (30 µl) were extracted twice with 5 ml of diethyl 
ether and reconstituted in 600 µl of PBSG.  Each sample was analyzed in duplicate.  The 
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Ultra-Sensitive Estradiol RIA Kit DSL-4800 (Diagnostic Systems Lab, Inc., Webster, 
TX, USA) was used to determine hormone concentration in the medium by following 
the protocol provided.  Extraction efficiency was 86% and the intra-assay CV was 4.46% 
calculated by using pooled pregnant ewe plasma. 
Lactate dehydrogenase activity 
 Cell membrane integrity was determined by analyzing the supernatant medium 
for LDH release into medium using the TOX-7 LDH assay kit (Sigma, St. Louis, MO, 
USA) as previously described (Azri-Meehan et al, 1992; Parrish et al, 1999a; Catania et 
al, 2003).  In this experiment, LDH was measured in the medium after 1 h and 6 h to 
assess the amount of damage that precision-cut slicing and incubation had on testis 
slices.  Following overnight storage at 4°C, 120 µl of supernatant medium were 
combined with equal portion of LDH substrate, dye solution and enzyme in 96-well, flat-
bottom plates in triplicate.  Each plate was covered and allowed to incubate at room 
temperature (RT) for 20 minutes until the reaction was terminated with 12 µl of 1 N 
hydrochloric acid (HCl).  Absorbance was measured with a microplate reader (Packard 
BS10000 Spectracount, Downers Grove, Il, USA) at a wavelength of 490 nm.  
Background optical absorbance was measured at 690 nm and was subtracted from 
primary measurements for each well (Decker and Lohmann-Matthes, 1988). 
Histoarchitecture 
 A preliminary study was conducted to evaluate changes in tissue maintenance 
and cellular morphology and to determine the optimal incubation time of precision-cut 
testicular slices (see Fig. 9).  In this initial time-course experiment, three mature (> 193 
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gm, each) equine testes were precision-sliced, as above, and incubated in medium alone 
at 32°C for 0, 3, 6, 12, 24 or 48 h time intervals.  Additionally, in order to observe 
changes due to mechanical slicing, some tissue was not precision-cut and was used as a 
control.  Sections (5 µm) from post-incubation testes slices on slides were stained with 
either hematoxylin and eosin (H&E) or 0.1% toluidine blue.  Slides were visualized and 
representative images of round seminiferous tubules of each time interval were captured 
as previously described (Fig. 9). 
Data analysis 
 Data are expressed as the mean ± standard error of the mean (SEM).  All data 
obtained from RIAs were log-transformed to establish a normal distribution histogram. 
Assumptions for normal random distribution were met prior to analysis by one-way 
ANOVA (SPSS Inc., Chicago, IL, USA) for both hormone values and mRNA 
quantification.  Tukey‟s post hoc test was used to separate means among groups with 
equal variances, whereas the Tamhane post hoc test corrected for unequal variances 
when present.  The level of statistical significance was a P ≤ .05. 
 Dose-response graphs for T and E2 are presented as percent hormone where 0 ng 
of oLH was set at 100 percent and mean values of 5, 50 and 500 ng of oLH were divided 
by the 0 ng value and multiplied by 100.  The data for mRNA quantification, (raw silver 
grain density values) were divided by area measured and reported as arbitrary units.  
Similar background values of the sense cRNA hybridization were subtracted. 
 
 
92 
 
Results 
Cellular architecture of precision-cut slices after culture 
 Experiments were initially performed to evaluate changes in the maintenance of 
cellular morphology in precision-cut testis slices.  Histologically, slice evaluations 
revealed maintenance of the testis tissue integrity after slicing and after culture for 0, 3 
and 6 h (Fig. 9, panels A-D). Seminiferous tubule structure and interstitial cells appeared 
normal at these time points.  Germ cells were properly organized into the basal and 
adluminal compartments.  Spermatogonia and spermatocytes were distinguishable and 
tubules with open lumens and spermatids were visible at each time point.  Myoid cells 
were apparent and provided distinction between the seminiferous epithelium and the 
interstitial space.  Cells in the interstitial spaces appeared uniform.  Although there was 
no change in tubular dimension or in amount of interstitial space observed after 12, 24 
and 48 h of culture, germ cell organization in the seminiferous epithelium and lumen 
architecture gradually changed after 6 h of culture (Fig. 9).  Germ cells began to migrate 
into the lumens of seminiferous tubules and germ cell organization markedly decreased.  
Vacuolization of spermatocytes and spermatids became more extensive and bi-nucleated 
cells were readily observed.  At 24 h, the loss of germ cell organization was apparent.  
Multi-nucleated cells were observed along the basal compartment of the seminiferous 
tubules and lumen architecture was lost.  Large nucleated cells were present where the 
lumen should be.   Cell types within the tubules were not distinguishable at 48 h.  At that 
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Figure 9.  Histoarchitecture of precision-cut equine testis slices following culture.  Mature 
testicular slices were placed into an in vitro organ culture system and maintained for 0 h (panel 
B), 3 h (panel C), 6 h (panel D), 12 h (panel E), 24 h (panel F) or 48 h (panel G).  Following 
incubation, slices were fixed in paraformaldehyde and paraffin-embedded.  Thin sections (5 µm) 
were cut, placed on glass slides and stained with hematoxylin and eosin.  Con (panel A) 
represents tissue not precision-cut or cultured and serves as a reference for normal tissue 
integrity.  The bar in panel G represents 50 µm. 
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time point, the lumen disappeared and the basement membrane began to break down 
which made it difficult to distinguish between the tubular epithelium and the interstitial 
space. 
LDH secretion 
 Cell membrane integrity was assessed by lack of LDH release during culture 
experiments (Parrish et al, 1999a; Catania et al, 2003).  No difference was found (p >.05) 
between 1 h and 6 h time points (data not shown).  LDH was measured at 0 h (reference 
control) and a 1.47- and 1.53-fold increase over control was observed at 1 h and 6 h, 
respectively.  These data demonstrate that tissue slicing did compromise plasma 
membrane integrity slightly, as expected, but 5 h of culture did not result in further 
damage.   
Testosterone and estradiol synthesis and release in response to oLH 
 Precision-cut testis slices of testes from peri-pubertal stallions were cultured with 
either 0, 5, 50 or 500 ng of oLH for 6 h.  Levels of T in medium represent androgen 
production and release by the tissue in culture.  Figure 10 shows the percentage increase 
of T in medium with either 5, 50 or 500 ng of oLH compared to culture medium without 
(0 ng) the addition of oLH.  The 0 ng oLH treatment represents basal steroid production 
and release by the testis tissue which averaged 1.12 pg of T per mg of tissue and was set 
to 100% in the graph.  Addition of oLH increased the amount of T in the medium more 
than 400%.  No significant differences were found between low, moderate and high 
doses.  However, the moderate and high doses demonstrated numerically higher T 
concentrations than the lowest dose of oLH. 
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 The E2 response trend was similar to the T response in that all treatments with 
oLH increased production of E2 at least 120% over the 0 ng oLH value (Fig. 10).  Peak 
E2 production was approximately 200% higher in the medium compared to the 0 ng oLH 
level.  These data indicate that the testis tissue in culture was viable and responsive to 
hormone. 
In situ hybridization localized and quantitated StAR, PDE3B and ODF2 mRNA 
 In situ hybridization was performed to localize and determine changes in the 
expression of StAR, PDE3B and ODF2 genes in precision-cut testis slices following a 6-
h culture with or without oLH treatment.  Hybridization signals for StAR protein mRNA 
(Fig. 11) revealed expression in the interstitial space of the testes within Leydig cells.  
Additionally, enhanced expression of StAR protein gene was observed in response to 
oLH challenges.  An oLH concentration-dependent increase was observed for StAR 
protein mRNA.  Quantitative data summarizing the in situ hybridization results are 
shown Figure 12.  The in situ data are presented as percent change in gene expression 
compared to control (same testicular tissue; but without precision-cutting or culture).  
The weakest amount of signal was observed in the 0 ng oLH group (Fig. 12).  The 5 ng 
and 50 ng oLH treatments both demonstrated StAR protein mRNA levels that were 
approximately 100% higher than the 0 ng group.  In the 500 ng treatment group, the 
StAR protein mRNA hybridization signal strength was higher than other groups and 
approximately 170% greater than controls.  Hybridization signals for PDE3B and 
ODF2  mRNAs  were  localized to the seminiferous tubules of the testicular parenchyma 
 
96 
 
 
 
Figure 10.  Percent testosterone (T) and estradiol (E2) hormone production and release into 
medium by precision-cut equine testis slices following oLH challenge.  Precision-cut slices were 
pre-incubated for 1 h prior to the addition of 0, 5, 50 or 500 ng oLH for 6 h.  Data are the mean ± 
SEM of triplicate replications of three (n = 3) stallion testis and are expressed as the percent 
steroid produced at each treatment point where 0 ng of oLH was set to 100%.  oLH stimulated an 
increase in both T and E2 production over non-treated tissue (0 ng oLH).  Means with different 
superscripts are different (P < 0.05) for T (white bars) and E2 (black bars). 
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Figure 11.  In situ hybridization of steroidogenic acute regulatory protein (StAR) mRNA levels 
in 6 h cultured precision-cut equine testis slices.  Paraformaldehyde-fixed slice sections were 
mounted onto slides and hybridized with 
35
S-labeled antisense StAR cRNA probe.  Following 
autoradiography, cell nuclei were counterstained with 1% Toluidine blue.  Black silver grains in 
the interstitial spaces on representative brightfield images (panels A, C, E, and G) show 
hybridization signals of StAR protein mRNA.  Small silver grains shine white in darkfield 
images (panels B, D, F and H).  Slices in medium were challenged with either 0 (panels A and 
B), 5 (panels C and D), 50 (panels E and F) or 500 ng of oLH (panels G and H).  StAR protein 
mRNA expression increased with increasing doses of oLH.  Panels I and J show the non-specific 
binding to sense StAR cRNA (a negative control).  The bar in panel I represents 100 µm. 
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Figure 12.  The percent change in gene expression for steroidogenic acute regulatory protein 
(StAR), phosphodiesterase 3B (PDE3B) and outer dense fiber of sperm tails 2 (ODF2) mRNA in 
precision-cut slices of equine testis tissue.  Slices were incubated for 6 h in the presence of 0, 5, 
50 or 500 ng of oLH.  Control represents testicular tissue that was not precision-cut or cultured.  
Data represent the mean ± SEM silver grain density values quantitated by in situ hybridization 
and are shown as the percent mRNA gene expression quantified at each treatment level where 
control was set to 100%.  Only StAR protein mRNA (black bars) was found to be different 
among treatments.  Means with different superscripts are different (P < 0.05).  
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as expected (Ing et al, 2004).  Although PDE3B and ODF2 mRNAs demonstrated strong 
hybridization signals, no increase in gene expression was observed in response to oLH 
treatments (Fig. 12). 
Discussion 
 This study provides evidence that the precision-cut in vitro culture system is a 
useful experimental model for investigating hormone responses of the equine testis.  
These results demonstrate a system in which testicular tissue slices are maintained and 
responsive to oLH for at least 6 h in culture.  The uniqueness of this in vitro culture 
system is that whole tissue, instead of dispersed cells, is used.  In addition, the cultures 
are highly reproducible.  One of the advantages of an in vitro system that utilizes 
precision-cut tissue is the consistent weight and thickness of each slice (Smith et al, 
1985).  Additionally, this system does not submerge the tissue continuously in the 
medium, but exposes the tissue to the medium and gas by floating the tissue on a grid in 
a continuously rotating culture vial (Parrish et al, 2002).  The precision-cut tissue in vitro 
culture system has been used to study other tissues from several different animal models.  
However, this is the first report in which precision-cut tissue slices have been used to 
examine equine testis.   
 Similar incubation periods with other tissues have been described using the 
PCTS in vitro system and have even been extended successfully to 24 h (Parrish et al, 
1999a; Schmelz et al, 2001; Catania et al, 2003).  In our experiments, we used the 6 h 
incubation time based on our histological observations and that other equine testicular 
whole tissue culture systems used similar time points (Donnelly et al, 2007).  Others 
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have cultured cell suspensions from equine testicular tissue for 12 h and 24 h 
(Eisenhauer and Roser, 1995; Hess and Roser, 2005).  In rats, an organ culture utilizing 
1-mm fragments of immature testicular tissue was maintained for 1 wk provided that 
FSH was added to the medium (Boitani et al, 1993).  Our medium did not contain FSH.   
It might be possible to extend the incubation time without compromising the tissue by 
using a different media preparation or by including additional growth factors to the 
medium. 
 An important finding in this study was the establishment of viability in the testis 
slices during incubation.  Viability was demonstrated by maintenance of 
histoarchitecture, the discovery that LDH leakage did not change from 1 h to 6 h, the 
increases in concentrations of T and E2 in the media and StAR protein mRNA in the 
tissue in response to oLH challenges.  In the stallion, T and E2 production and release is 
regulated by equine LH. Equine Leydig cells treated with equine luteinizing hormone 
(eLH) demonstrate a dose-dependent increase of T and E2 in the medium (Eisenhauer 
and Roser, 1995).  Our findings were similar in that slices treated with oLH significantly 
increased their production and release of T and E2 over untreated slices and indicated 
active steroidogenesis in the tissue and/or release by the tissue.  However, the percentage 
increase in T and E2 in response to oLH was not as dramatic in the testis slices compared 
to previously reported increases obtained in cultured Leydig cells (Eisenhauer and 
Roser, 1995; Hess and Roser, 2005).  These differences may be explained by the 
different species of LH (ovine) used in these experiments and possibly the peripubertal 
stage of the stallions. 
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 In situ hybridization results confirmed our hypothesis that expression of StAR 
protein mRNA would increase with increasing doses of oLH.  It has been well 
documented that LH induces StAR protein gene expression (Clark et al, 1994; Stocco 
and Clark, 1996).  Interestingly, one report showed a 1.4- and 3-fold increase in StAR 
expression in the testicular tissue of young and middle-aged rats, respectively, in 
response to LH treatment (Luo et al, 1998).  Similarly, our data demonstrated an average 
2.3-fold increase in stallion testicular tissue.  Of the genes evaluated in this study, the 
role of StAR protein is the most understood in the testis.  StAR protein is responsible for 
cholesterol delivery from the outer membrane of the mitochondria to the inner 
mitochondrial membrane enzyme cytochrome P450 cholesterol side chain cleavage 
(P450scc).  This transport serves as the rate-limiting step in the production of steroids 
(Clark et al, 1994).  StAR protein-null mice have a significant reduction in steroid 
production (Manna and Stocco, 2005).   StAR protein transcripts have been localized in 
tissues that synthesize steroids including Leydig cells of testes, adrenal glands, ovary, 
placenta, and more recently the brain (Pollack et al, 1997; Manna and Stocco, 2005; 
Webber et al, 2006).  
 In conclusion, the precision-cut tissue slice in vitro culture system provides a 
novel tool to investigate equine testicular function.  This system maintains whole tissue 
slices in a state where regulation of steroidogenesis and gene expression by cell stimuli 
can be explored.  Future studies using this system could be useful in determining the 
effects of various exogenous compounds such as drugs on testicular tissue functions.  
Ultimately, this organ culture system could be used not only for reproductive studies in 
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stallions, but could be validated for use in a variety of species. 
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CHAPTER VI 
 
CONCLUSIONS 
 
 The implementation of novel laboratory techniques, such as GIFT, ICSI, and 
oocyte transfer (OT) has greatly enhanced our knowledge of mammalian reproductive 
biology.  However, as the field was concentrating on achieving high conception rates, 
little attention was paid to the causes of subfertility and infertility.  As a result, the 
diagnosis and treatment of reproductive inefficiency has become a critical area of 
investigation in both humans and animals alike (Ehmcke and Schlatt, 2008).  It has been 
reported that 15% of the human population is affected by some type of 
infertility/subfertility (De Krester and Baker, 1999). In farm animals, poor reproductive 
performance can lead to loss of income and genetic progress in populations due to 
failure to pass on viable gametes.  Previous research has focused primarily on the female 
system; however, attention has shifted towards identifying the causative mechanisms in 
males.  Approximately one-quarter of infertile/subfertile cases are male specific, and are 
identified as either irreversibly subfertile or having only limited treatment options 
(Swerdloff and Wang, 1993).  References in the literature state that a subfertile male is 
an individual with abnormal semen quality and quantity which is reported to affect five 
percent of all men (Hirsh, 2003).  This deficiency is also evident in the livestock species.  
Breeding stallions are especially prone to fertility problems, as evidenced by reports that 
approximately 38% of all prospective stallions fail a breeding soundness examination 
(Blanchard and Johnson, 1997).  To date, there are few treatment options available once 
a male has been diagnosed as subfertile (Ball, 2008; Carnevale, 2008).  Therefore, these 
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experiments were purposefully designed to investigate equine testicular genes and their 
role in regulating spermatogenesis and steroidogenesis.  In addition, the knowledge 
gained by these investigations should expand the currently available therapies and 
enhance therapy development for the treatment of male infertility using the stallion as a 
model. 
 Two seminal articles initiated this project which discussed the differential 
shading of equine testicular parenchyma in peripubertal stallions and the possible gene 
differences between these two tissues (Clemmons et al, 1995; Johnson et al, 1997).  
Using the future research suggestions by these authors, we utilized microarray 
technology to evaluate gene expression differences in three equine peripubertal testes 
that exhibited both spermatogenically active (light testicular parenchyma) and 
spermatogenically inactive (dark testicular parenchyma) tissue in the same testicular 
samples.  The microarrays evaluated over 9,000 gene products and the analysis 
determined that 93 genes were differentially expressed in at least two of the three horses.  
Of these, 58 were preferentially expressed in dark testis tissue and 35 were preferentially 
expressed in light testis tissue.  The largest differential expression revealed was for the 
light specific ODF2 gene (-7.8) and was one of five genes discovered to be differentially 
expressed in all three horses.  The other four included the dark specific genes DYS (3.7), 
GLG1 (2.5), and DOC1 (2.3) and the light specific gene PDE3B (-4.4).  In addition, a 
second microarray was conducted which evaluated differential gene expression in the 
testes of a fertile and subfertile stallion.  Using similar criteria, this microarray revealed 
233 gene products that were differentially expressed.  Of these, 122 genes were more 
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highly expressed in the fertile stallion while 111 appeared more highly expressed in the 
subfertile stallion.  One of the gene products found to be more highly expressed was 
StAR protein mRNA which demonstrated a balanced difference value of -1.7 in fertile 
tissues. 
 Interestingly, results from the two different microarrays unveiled nine genes that 
were differentially expressed in both the light/dark and fertile/subfertile microarray 
experiments.  Of these, four candidate genes (GNG3, SERPINF1, IFI6 and CITED1) 
were preferentially expressed in both the light parenchyma and in the fertile testis of 
stallions.  These results suggest that these gene products could be potential markers of 
fertility in the stallion.  The other five candidate gene products are more challenging to 
understand because their balanced differential expression was more evident in dark 
parenchyma and fertile tissue (DHCR24, GSTO1, GLG1, and SC4MOL) or in light 
parenchyma and subfertile tissue (CDC2).  Currently, the literature provides some 
functional explanation for DHCR24, GSTO1, GLG1, and CDC2.  DHCR24 is involved 
in the biosynthesis of cholesterol, GSTO1 is associated with cellular detoxification, 
GLG1 is a transport protein of the Golgi apparatus and CDC2 aids in the regulation of 
the cell cycle (Wechsler et al, 2003; Board et al, 2000; Mourelatos et al, 1995; Konishi et 
al, 2002).  Limited information is available about SC4MOL, other than it seems to have 
enzymatic properties.  Studies of these genes targeted at investigating differences in age 
of stallions, circulating hormone levels, events surrounding lumen formation in 
seminiferous tubules, and their expression in specific germ cells may help answer why 
these gene products seem to be expressed in uncommon testicular tissue.  Overall, the 
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use of microarrays to study gene expression in the horse testis was highly successful 
revealing several candidate genes worthy of investigation.  Continued investigations 
could potentially uncover the specific genes responsible for the current idiopathic nature 
of male infertility. 
 Some of the genes found by microarray experimentation were used for further 
investigation in to testicular function and regulation and included DYS, DOC1, ODF2, 
PDE3B and StAR protein.  PDE3B and StAR protein, specifically, were evaluated by in 
situ hybridization to determine differences in mRNA expression in testicular tissues of 
mature stallions and mature and immature cryptorchid stallions.  PDE3B was localized 
to the seminiferous tubules and significant differences in gene expression, determined by 
quantitating mean silver grain densities localized in the seminiferous tubules, were found 
among ten mature stallions.  Interestingly, one stallion categorized as subfertile had a 
significantly lower mean value for PDE3B mRNA compared to the other nine stallions.  
We originally hypothesized that relationships would be found for PDE3B mRNA when 
compared to semen parameters, especially DSO, and circulating hormone values, 
specifically T, for the ten mature stallions.  Although no significant correlations were 
revealed, our research demonstrated that additional investigations in the relationship 
between the expression of the PDE3B gene and DSO are necessary with more stallions.  
It would be beneficial to evaluate the relationship of PDE3B mRNA in multiple stallions 
demonstrating both high quality and poor quality semen characteristics.  In addition, 
PDE3B mRNA was evaluated in one-year-old and three-year-old unilateral cryptorchid 
stallions.  In this model, only the descended testes of the three-year-old stallions 
107 
 
demonstrated expression of the PDE3B gene.  Future studies should investigate the 
expression of PDE3B mRNA in the seminiferous epithelium and correlate expression to 
tubule stage (Ing et al, 2004; Laughlin et al, 2009).  Our results indicated that not all 
spermatogenic cell types express the PDE3B gene which suggests that it may be 
involved in the regulation of specific changes in spermatocytes and spermatids. 
 Likewise, StAR protein mRNA expression was evaluated by in situ hybridization 
and quantitated.  Similar to PDE3B, StAR protein mRNA expression was different 
among the ten mature stallions.  However, StAR protein mRNA was localized to the 
interstitial space surrounding the seminiferous tubules.  We hypothesized that significant 
relationships between StAR protein gene expression and semen parameters such as DSP 
and DSO and circulating hormones, such as T and E2, would be revealed since StAR 
protein is responsible for cholesterol transport into the mitochondria. However, the only 
significant relationship found was between StAR protein and testosterone.  One 
limitation to these correlative results is that DSP/horse, DSO, and apoptotic rate were not 
determined for all stallions used in this experiment.  In the unilateral cryptorchid 
stallions, StAR protein gene expression was highest in the descended testes from three-
year-old stallions when compared to the others, as expected.  However, the retained 
testes of the one-year-old horses demonstrated a higher level of StAR protein mRNA 
expression when compared to their one-year-old descended testes.  One research avenue 
that remains to be pursued is the correlation between StAR protein gene expression and 
number of Leydig cells per area.  Our studies did not evaluate Leydig cell numbers in the 
tissues.  However, this information could explain why immature retained testes exhibit 
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greater StAR protein gene expression than testes that have appropriately descended into 
the scrotum. 
 We have also demonstrated that one in vitro culture system is a valuable tool for 
investigating gene regulation mechanisms in testes tissues.  Specifically, the precision-
cut tissue slice (PCTS) in vitro culture system was utilized to evaluate its usefulness as a 
novel tool to investigate equine testicular function.  The use of this system revealed that 
the slices produced by the precision-cutting technique were highly reproducible and 
were not different in weight or thickness.  In this system, equine testicular tissue slices 
were incubated for six hours at 32°C.  Although the slicing procedure did cause some 
damage to cells, LDH leakage did not change from one hour to six hours indicating the 
maintenance of the cell membranes.  Precision-cut equine testicular slices were 
challenged with concentrations of 0, 5, 50 and 500 ng/ml of oLH and the tissue did 
respond by releasing T and E2 into the medium during in vitro culture.  The addition of 
oLH increased T and E2 at least 400% and 120%, respectively, over the 0 ng control 
value.  Testicular gene expression was also assessed with in situ hybridization 
methodology for StAR protein, PDE3B and ODF2 mRNAs.  In situ hybridization 
revealed an oLH concentration-dependent increase in the concentration of StAR protein 
mRNA in Leydig cells.  No differences were observed for expression of PDE3B or 
ODF2 genes in seminiferous tubules among treatment groups, as expected.  These 
results demonstrate the value of in vitro culture of the precision-cut tissue slices for 
studies of steroidogenesis and gene expression in the stallion testes. 
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 Future studies involving equine testicular tissue and PCTS should include 
attempts to extend incubation time without compromising the tissue and determining the 
effects of various exogenous compounds such as drugs on testicular tissue functions.  In 
our medium, we did not include testosterone or FSH.  Previous work has indicated that 
these two hormones may allow tissue to survive longer in culture (Boitani et al, 1993; 
Eisenhauer and Roser, 1995).  One of the limitations to studying spermatogenesis using 
culture systems is that the complete process of spermatogenesis takes a long time, 
approximately 57 days (in the stallion), and we are currently only capable of incubating 
tissue for several hours at a time before normal testicular morphology is lost (Laughlin et 
al, 2009).  In addition, the role of the PDE3B gene in the testis is not known.  PCTS 
could be used to challenge testicular tissue with FSH.  FSH has been shown to affect 
phosphodiesterase activity in the testis of rats but the specific function of that activity 
remains unknown (Conti et al, 1983). 
 Within the seminiferous tubules of the testes, germ cells undergo a series of 
divisions ultimately leading to the production of spermatozoa.  These processes are 
collectively termed spermatogenesis, and are regulated by endocrine, paracrine and 
autocrine communications within the testes.  Therefore, a series of experiments were 
conducted using the stallion as a model to provide a better understanding of the specific 
gene products involved in spermatogenesis and useful methods to investigate their 
functions.  Ultimately, this research could lead to the development of new strategies to 
treat and/or prevent conditions that cause testicular dysfunction.  The studies discussed 
here provide new insight into the processes involved in spermatogenesis and novel tools 
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for investigating testicular function.  In addition to our studies in stallion infertility, 
many of the methods developed here can lead to new research approaches in other 
species including humans.  The ability to accurately identify aberrant molecular 
mechanisms that cause reproductive inadequacies may increase the number and efficacy 
of current treatments available to all clinicians and researchers. 
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APPENDIX A 
 
Table A.  Gene products preferentially expressed in stallion testis tissue in both the light 
vs. dark microarray experiment (Study 1A) and the fertile vs. subfertile microarray 
experiment (Study 1B). 
 Microarray Study 1A Microarray Study 1B 
 Gene  Light Dark Fertile Subfertile 
 Products Parenchyma Parenchyma Testis Testis 
GNG3 -2.0  -1.8 
 
SERPINF1 -1.8  -2.1 
 
IFI6 -2.3  -2.0 
 
CITED1 -2.2  -2.0 
 
DHCR24  2.5 -2.9 
 
GSTO1  2.0 -1.8 
 
GLG1  2.5 -2.9 
 
SC4MOL  1.6 -1.7 
 
CDC2 -2.3   1.7 
Gene products are listed according to accepted abbreviations.  Numbers represent 
balanced difference values for each gene product.
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APPENDIX B 
 
Table B.  Mean values of gonadal characteristics and circulating hormone concentrations for ten 
mature horses. 
Testis and 
Semen  Individual Stallions 
Parameters 1955 75 1906 Arab 1959 1861 1859 1957 Lucky Peppy 
Parenchyma 
Weight (g) 154.27 199.60 171.85 217.68 243.46 251.64 201.80 209.93 169.54 152.11 
 
DSP (10
6
) 
 Per gram 15.62 15.91 19.97 16.76 13.40 15.68 14.79 13.17 16.86 13.74 
 Per testis 2094 3176 3482 3648 3262 3947 2984 2765 2858 2091 
 Per horse 4680 6703 6566 7270 6421 7918 5492 4552 6450 NA 
 
DSO (10
6
) 4580 8534 5507 8142 5323 7714 6253 5358 5791 NA 
 
Apoptotic 
Rate  15.18 4.56 7.12 6.26 7.14 3.89 5.61 7.14 NA 9.98 
 
T (ng/ml) 1.15 1.84 1.21 2.20 1.17 2.05 1.31 1.46 1.05 0.54 
E2 (pg/ml) 48.89 72.54 40.93 59.98 68.41 66.40 62.55 45.20 28.20 19.27 
LH (ng/ml) 13.31 3.63 3.84 8.74 7.13 4.11 6.16 7.18 5.30 5.26 
FSH (ng/ml) 3.55 2.18 12.68 2.06 3.37 2.71 2.58 4.57 4.82 3.99 
Inhibin (ng/ml) 3.28 5.45 2.52 3.68 6.25 6.50 4.55 2.23 1.63 1.12 
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APPENDIX C 
 
PROTOCOL FOR IN SITU HYBRIDIZATION 
A.  In Vitro Transcription (Riboprobe or Probe Transcription) 
 
 1.  Place DNA templates (anti-sense gel chunks cut from low-melt gel) at 70°C 
 for 10 minutes, then move to 37°C heat block until ready to use. 
 
 2.  Add the following reagents to the reaction mix in order at room temperature 
 (RT) or DNA will precipitate. 
 
  Reaction mix (can make ½ reactions with 10 µl total volume w/2X 
35
S) 
  DEPC H2O       3.3 µl 
  5X transcription buffer     4.0 µl 
  1 mM DTT       0.2 µl 
  RNasin       0.8 µl 
  33 mM rATP + rGTP + rCTP (made by adding equal  
  volumes of the three 100 mM rNTPs)   0.3 µl 
  100 uM UTP (1:100 dilution of 10 mM rUTP stock)  2.4 µl 
  DNA template (gel chunk)     4.0 µl 
  
35
S-UTP (50 uCi of label, radioactive)   4.0 µl 
  RNA polymerase (either T7 or SP6 depending on temp.) 1.0 µl 
  Final Volume       20.0 µl 
 
 3.  Incubate the reaction at 37°C for 1-2 hours. 
 
 4.  Conduct probe test  
 
  a.  after 1 hour, remove 2 µl of transcription reaction, place in new tube 
  with 8 µl of formamide. 
 
  b.  Heat denature the sample at 70°C for 10 minutes and load samples on 
  an 8M urea, 5% acrylamide short, fat gel (probe test gel).  Load 5 µl of 
  dye marker in extra well to evaluate migration. 
 
  c.  Run probe test gel for 45 minutes at 40 mAmps. 
 
  d.  Allow transcription reaction to continue for another hour. 
 
  e.  Expose film wrapped in Saran wrap for 1 hour or overnight. 
 
  f.  Protect yourself and unexposed film from radiation contamination. 
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  g.  Assess probe quality and continue if acceptable. 
   100 x 10
6
 cpm (total) = good probe quality 
   >60 x 10
6
 cpm = fair probe quality 
   < 60 x 10
6
 cpm = poor probe quality (discard) 
 
  h.  Add 1 µl of RQ1 DNase and 1 µl RNasin to each transcription  
  reaction.  Vortex and incubate at 37°C for 15 minutes. 
 
  i.  Store probes at -80°C overnight if necessary. 
 
 5.  Clean Probes 
 
  a.  Develop film and proceed with probe cleanup if all probes are  
  acceptable. 
 
  b.  Add 30 µl of sterile H2O to each probe (bring total volume up to 50 
  µl). 
 
  c.  Add 50 µl phenol chloroform isoamyl (PCI) (pH 5) to probes, vortex 
  on high for 1 minute, and centrifuge at 10,000 rpm for 4 minutes. 
 
  d.  Remove upper aqueous layer and add 50 µl of chloroform isoamyl 
  (CI) to tubes, vortex on high for 1 minute and centrifuge at 10,00 rpm for 
  4 minutes. 
 
  e.  Remove upper aqueous layer and place in Roche RNA MiniQuick 
  Spin Columns (Roche, Switzerland).  Follow procedure outlined by 
  Roche protocol to resuspend columns and spin samples. 
 
  f.  Determine probe counts by adding 1 µl of cleaned probe to 5 ml of 
  scintillation fluid.  Use program 5 on Beckman counter. 
 
  g.  Heat probes at 68°C for 15 minutes before using as probe for  
  hybridization. 
 
B.  Day 1 Slide Preparation 
 
 1.  Remove slides from -20°C freezer and let sit until RT. 
 
 2. Tissue on slides have been embedded in paraffin, therefore, must deparaffinize 
 sections by dipping slides through the following steps. 
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   CitriSolv
TM
 (Fisher Scientific) 2 min 
   100% Ethanol (ETOH)  2 min 
   100% ETOH    2 min 
   95% ETOH    2 min 
   70% ETOH    2 min 
   50% ETOH    2 min 
 
 3.  Next, sections are fixed in 4% paraformaldehyde (pH 7.4) at 4°C for 10 
 minutes.  Use 250 ml per slide rack. 
 
   4% paraformaldehyde (to make 500 ml) 
   Work in fume hood.  Heat 100 ml nanopure H2O to 60°C. 
   Add to beaker 20 g of paraformaldehyde 
   1.25 g NaOH pellets 
   50 ml of 10X PBS 
   Bring volume up to 500 ml with nanopure water and stir. 
   Wait to pH until solution clears (approximately 10 min). 
 
 4.  Wash slides in 0.5X SSC for 5 minutes at RT. 
   0.5X SSC 
   25 ml 20X SSC 
   975 ml DEPC H2O 
 
 5.  Wash slides in Proteinase K (20 µg/ml in RNase buffer) for 10   
 minutes at RT. 
 
 6.  Wash slides in 0.5X SSC for 5 minutes at RT. 
 
 7.  Preheat hybridization buffer to 55°C. 
 
   Prehybridization and Hybridization Buffer (for 50 ml) 
   25 ml formamide 
   6 ml 2.5 M NaCl (5 M = 3 ml) 
   1 ml 1 M Tris-pH8 
   0.5 ml 0.5 M EDTA 
   1 ml 0.5 M sodium phosphate (500 µl at conc. Of 10 mM) 
   5 g Dextran sulfate 
   1 ml 50X Denhardt‟s 
   5 ml DEPC H2O 
   Difficult to dissolve Dextran sulfate.  Incubate on a rocker at 37°C 
   for 4 hours.  Immediately prior to use, add 1/10 volume of 1M 
   DTT. 
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 8.  On the slides, outline (circle) each section with rubber cement to form a  
 reservoir for the addition of probe. 
 
 9.  Dry slides by blotting and place in a hybridization chamber.  Soak a paper 
 towel in box buffer and place in bottom of container. 
 
 10.  For large sections such as two equine testis sections per slide you need 
 50 µl of probe per section.  To determine how much probe solution to place on 
 slides: 
 
   First, determine how many total section you will be covering per 
   probe. (in this example we will use 1 section). 
   Add 1mM DTT (a total of 10% of overall probe solution to a 50 
   ml disposable tube.  In this case it would be 5 µl.  DDT must be 
   made fresh. 
   Add 2 µl of yeast tRNA for each section to be covered to 50 ml 
   tube..  In this case it would be 2 µl. 
   Determine the amount of probe to use by the following equation: 
 
    500,000/previously determined cpm = X 
 
   Add X value to 50 ml tube. 
   Bring up total volume to 50 µl with Hybridization buffer. 
 
 11.  Heat probe solution at 70°C for 5 minutes and then place on ice  
  until ready to use. 
 
 12.  Cover sections with probe solution.  Take care in completely covering 
  sections.  Use the bottom side of a pipette tip to spread solution over each 
  section.  Do not mix solutions among adjacent sections. 
 
 13.  Cover humidity chamber with slides inside and incubate overnight at  
 55°C in hybridization oven. 
 
C.  Day 2 Slide Washing 
 
 1.  Heat a shaking water bath to 55°C.  Make 2 liters of 0.1 SSC, 10 mM  
 2-mercaptoethanol (βME), 1 mM EDTA buffer and warm in water bath. 
 
   2 L of 0.1 SSC, 10 mM βME, 1 mM EDTA 
   10 ml 20X SSC 
   154 µl 13M βME 
   4 ml 0.5 M EDTA 
   Bring up to 2000 ml with d H2O 
136 
 
 2.  Place slides in a rack and wash as follows (the waste is radioactive and  
 must be disposed of properly). 
 
   1.  2X SSC with 10 mM βME, 1 mM EDTA, 10 minutes at RT. 
 
   2.  Repeat step 1. 
 
   3.  Add 400 µl of 10 ng/ml RNaseA (previously boiled) to 200 ml 
   of RNase buffer.  Dip slides in rack for 30 minutes at RT.   
   Following this wash, waste is not considered radioactive. 
 
   4.  2X SSC with 10 mM βME, 1 mM EDTA, 200 ml, 10 minutes, 
   RT. 
 
   5.  Repeat step 4. 
 
   6.  Place slides in a large container and cover with 0.1X SSC with 
   10 mM βME, 1 mM EDTA (approximately 1 liter).  Place  
   container with slides into a gently shaking water bath for a  
   minimum of 1 hour. 
 
   7.  Repeat step 6. 
 
   8.  Wash in 250 ml of 0.5X SSC for 10 minutes at RT. 
 
   9.  Repeat step 8. 
 
 3.  Dehydrate slides in the following ethanol washes: 
   50% ETOH + 0.3 M NH4Ac, 2 minutes, RT 
   70% ETOH + 0.3 M NH4Ac, 2 minutes, RT 
   90% ETOH + 0.3 M NH4Ac, 2 minutes, RT 
 
 4.  Remove rubber cement by lifting the edge with needle. 
 
 5.  Blot slides and dry in racks on a tray for 3 hours at 37°C. 
 
 6.  Line up slides in order on a film cassette.  Tape down slides on edges to 
 cassette insert.  Expose slides to film at RT.  Time of exposure depends on 
 quality of probes used.  If probes are above 100,000 cpm, then expose over night 
 to assess quality.  If less than 100,000 cpm, expose for 2 -3 days.  Make sure to 
 wrap whole cassette in foil in the darkroom. 
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D.  Day 3 Dipping of Slides 
 
 1.  If autoradiograph is acceptable, the slides are dipped in Kodak NTB2 nuclear 
 emulsion in complete darkness. 
 
 Items needed for Emulsion, Dipping, and Developing Slides in Dark Room 
 42° water bath 
 Emulsion (Kodak NTB2).  When emulsion is received, aliquot into 5 ml 
 containers.  When ready to use for slides, use 2 aliquots plus 5 ml of d H2O. 
 113.4 ml d H2O 
 500 ml flasks 
 50 ml tubes 
 Empty slide boxes to place freshly dipped slides for storage and development 
 Aluminum foil 
 Dryrite to reduce moisture in slide boxes 
 Kimwipes 
 Developer, Fixer, d H2O 
 15°C bath, ice bucket and thermometer 
 3 two liter beakers for rinsing 
 
 2.  Emulsion is diluted 2:1 with water.  Emulsion needs to be at 42°C and poured 
 carefully into a dipmizer without bubbles. 
  
 3.  Dip and develop a test slide to evaluate emulsion quality. Temperature of 
 developer, water and fixer should be at 42°C (develop for 5 minutes, water 30 
 seconds, fixer 5 minutes, running water for 5 minutes). 
 
 4.  Dip experimental slides in emulsion at 42°C two times.  Carefully clean back 
 of slides of residual emulsion.  Set slides at a diagonal, to allow for excess 
 emulsion to slowly drain off glass, allowing only ends of slides to touch surfaces.  
 Do not lay slides flat.  Allow 15 minutes to expire and rotate slides 180° (this 
 step keeps emulsion from pooling on ends which makes for uneven surfaces 
 when trying to apply cover slip).  Transfer slides to a slide box with dryrite 
 wrapped in kimwipe  placed in corner of box. 
 
 5.  Place slide box with slides into bread box without lid for 2 hours.  This step 
 minimizes dust accumulation on slides and allows them to dry completely. 
 
 6.  Place lid on slide boxes, tape edges, and completely wrap boxes in foil.  Label 
 boxes carefully.  Store boxes at 4°C until time to develop. 
 
E.  Developing of Slides 
 
 1.  Remove slides and allow to warm to RT. 
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 2.  Develop and stain using the following protocol: 
 
 Kodak Developer, 10 minutes, dilute 1:1 with water at 15°C in dark 
 Distilled Water, 30 seconds 
 Fixer with Hardener, 15 minutes.  Mix carefully. 
 Water, 5 minutes, 2 times, under running water, can turn on light after this step, 
 slides must remain wet at this point 
 1% Toluidine Blue, 3 minutes 
 Water, 45 seconds, 2 times 
 50% EtOH, 3 minutes 
 70% EtOH, 2 minutes 
 95% EtOH, 2 minutes, 2 times 
 
 3.  Use permount to cover slip slides.  Place one drop of xylene and one drop of 
 permount on each section.  Carefully lay coverslip onto slide.  Remove bubbles 
 by gently pushing down with pipette tip. 
 
F.  Recipes for in situ hybridization solutions 
 
 1.  20X SSC 
  173 g Sodium Chloride 
  88.2 g Sodium Citrate 
  Bring up to 1 liter with distilled water.  Add 1 ml Diethyl Pyrocarbonate 
  (DEPC) and shake vigorously.  Place at 37°C overnight.  Autoclave for 
  40 minutes. 
 
 2.  0.5X SSC 
  25 ml 20X SSC 
  975 ml DEPC water 
 
 3.  2X SSC with 10 mM βME + mM EDTA 
  100 ml 20X SSC 
  77 µl 13 M βME 
  2 ml 0.5 M EDTA 
  Bring up to 1 liter with DEPC water 
 
 
 4.  0.1X SSC with 10 mM βME + mM EDTA 
  10 ml 20X SSC 
  154 µl 13 M βME 
  4 ml 0.5 M EDTA 
  Bring up to 2 liters with DEPC water 
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 5.  RNase Buffer (500 mM NaCl, 10 mM Tris) pH 8.0 
  50 ml 5 M NaCl 
  5 ml 1 M Tris, pH 8.0 
  445 ml Nanopure water 
 
 6.  Box Buffer (4X SSC + 50% formamide) 
  100 ml 20X SSC 
  250 ml formamide 
  150 ml DEPC water 
 
 7.  Hybridization Buffer 
  25 ml formamide 
  6 ml 2.5 M NaCl (5 M = 3 ml) 
  1 ml 1 M Tris-pH8 
  0.5 ml 0.5 M EDTA 
  1 ml 0.5 M sodium phosphate (500 µl at conc. Of 10 mM) 
  5 g Dextran sulfate 
  1 ml 50X Denhardt‟s 
  5 ml DEPC H2O 
  Difficult to dissolve Dextran sulfate.  Incubate on a rocker at 37°C  
  for 4 hours.  Immediately prior to use, add 1/10 volume of 1M  
  DTT. 
 
 8.  50X Denhardt‟s (to 500 ml with DEPC water) 
  5 g Ficoll 400 
  5 g Polyvinylpyrrolidone 
  5 g BSA (Pentax Fraction V) 
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APPENDIX D 
 
RADIOIMMUNOASSAY PROCEDURE FOR MEASURING MEDIA 
CONCENTRATION OF TESTOSTERONE FOLLOWING PRECISION-CUT IN 
VITRO CULTURE 
A.  Prepare PBSG 
 1 L of PBSG 
 NaCl   8.170 g 
 NaH2PO4H2O  0.856 g 
 Na2HPO4  0.540 g 
 EDTA   3.720 g 
 Thimerosal Powder 0.100 g 
 
 1.  Dissolve above ingredients in 1000 ml beaker with double distilled H2O  
     (approximately 900 ml). 
 2.  Measure pH and adjust to 7.4. 
 3.  Add 1.0 g of gelatin (Knox) to EDTA-PBS solution and stir on “low” heat for  
           2 h to dissolve gelatin. 
 4.  Let PBSG cool to RT before use (store at 4°C). 
 
B.  Prepare Charcoal Suspension 
 500 ml of Charcoal Dextran Suspension 
 Charcoal Norit SPXX  3.1250 g 
 Dextran Pharmacia T-70  0.3125 g 
 PBSG 600 ml 
 
 1.  Use fresh charcoal suspension within two weeks old. 
 2.  Stir charcoal suspension for 6 h prior to use. 
 3.  In a 1000 ml beaker, combine charcoal, dextran, and PBSG. 
 4.  Stir to mix at 4°C for 30 m prior to each use.. 
 
C.  Assay Methodology 
 1.  Ether Extraction of Media Samples 
  a.  Extractions are conducted in duplicate 
  b.  Label 16 x 125 mm borosilicate glass disposable culture tubes (VWR 
       Scientific Inc. [KIMAX
®
51] and additional set of 12 x 75 mm glass 
       tubes to match large tubes. 
  c.  Pipet 500 μl of unknown sample into appropriately labeled 16 x 125 
       glass tubes. 
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  d.  Under a fume hood, add 5 ml of anhydrous ether (EM Science,  
       Cincinnati, OH) to each 16 x 125 mm tube with unknown. 
  e.  Vortex 4 tubes by hand for 1 min. 
  f.  Place up to 4 tubes at a time into liquid nitrogen (put liquid nitrogen 
      into Styrofoam ice chest with rack to hold tubes) for 10-15 s until 
      media freezes (bottom layer only). 
  g.  Remove tubes from liquid nitrogen and decant liquid into  
       appropriately labeled 12 x 75 mm glass tube. 
  h.  Place 12 x 75 mm glass tubes into nitrous gas dryer (Multivap  
       Analytical Evaporator, Organomation, South Berlin, MA) containing 
       37°C distilled H2O until tubes are dry. 
  i.  Reconstitute by adding 500 μl of PBSG to each dried tube and vortex. 
  j.  Samples can be stored at 4°C if not used immediately. 
 
D.  Setting up the Assay 
 1.  Label three tubes T, N, 0 and pipet 800 µl, 600 µl, and 500 µl PBSG in 
 duplicate into each tube, respectively. 
 2.  Pipet 500 µl of standard into appropriately labeled tubes, in duplicate.  
 Standards should consist of a total of 12 tubes ranging from 3.9 pg/tube to 8,000 
 pg/tube. 
 
  If new standards are needed: 
  Take 320 µl of Testosterone (stock) and add 19.68 ml of medium  
  (DMEM with FBS).  This equals 8,000 pg/500 µl of standard.  Make 
  dilutions by taking 10 ml of 8,000 standard and add to 10 ml of medium.  
  This makes 4,000 pg/500 µl of standard.  Continue until reach 3.9 pg/500 
  µl. 
 
 3.  Add 100 µl of testosterone antibody (Colorado State University) to each tube 
 except for T and N tubes. 
 4.  Add 100 µl of
 3
H-testosterone tracer (Perkin Elmer-NEN, Boston, MA) to 
 every tube. 
 5.  Mix the tubes by shaking, covered with foil.  Incubate at 4°C overnight. 
 6.  Add 200 µl of charcoal solution to each tube except for the T tube (in cold 
 room). 
 7.  Vortex and incubate at 4°C for 15 minutes. 
 8.  Centrifuge samples for 20 minutes at 2800 rpm (2282 x g). 
 9.  Transfer samples into scintillation tubes containing 5 ml of Ecolume 
 biodegradable scintillation cocktail (MP Biomedicals, Irvine, CA).  Cap tubes 
 and shake gently. 
 10.  Count the samples for 1 minute with Beckman Beta counter. 
 11.  Use AssayZap program to calculate concentrations of unknowns in 
 comparison to a known standard curve. 
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APPENDIX E 
RADIOIMMUNOASSAY PROCEDURE FOR MEASURING MEDIA 
CONCENTRATION OF ESTRADIOL FOLLOWING PRECISION-CUT IN 
VITRO CULTURE 
Followed protocol for Diagnostic Systems Lab, Inc. Ultra-Sensitive Estradiol RIA Kit 
(DSL – 4800) with the following changes: 
 
1.  Begin with double extracted samples and use 100 µl of unknown, reconstituted with 
 500 µl of PBSG.  All samples run in duplicate. 
2.  Allow all reagents to reach RT (~25°C) and mix liquid reagents by inversion. 
3.  Label and arrange tubes in duplicate for Total Counts, Non-Specific Binding (NBS), 
 Standards, Controls, and unknowns. 
4.  Add 200 µl of standards, controls or unknowns to appropriate tubes.  To NSB tubes, 
 add 300 µl of the 0 pg/ml estradiol standard. 
5.  Add 100 µl of estradiol antiserum to al tubes except NSB and total count tubes. 
6.  Vortex all tubes, cover and incubate at RT for 1 hour. 
7.  Add 100 µl of estradiol [I-125] reagent to each tube. 
8.  Vortex all tubes, cover and incubate at RT for 2 hours. 
9.  Add 1 ml of precipitating reagent to all tubes except total count tube.  Vortex and 
 allow to stand at RT for 20 minutes. 
10.  Centrifuge all tubes, excepts total count tubes, for 20 minutes at 3,000 rpm, 4°C. 
11.  Decant and count in gamma counter for 1 minute. 
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APPENDIX F 
 
HEAT INACTIVATED, CHARCOAL STRIPPED PROTOCOL FOR 
REMOVING EXOGENOUS STEROIDS FROM SERUM 
Recipe:  Dextran-coated charcoal solution (DCC; 10X) 
  100 ml water 
  5 g charcoal (Sigma) 
  0.5 g dextran (70,000 MW) 
  8.2 g NaCl 
 
1.  Add 250 µl of 10X DCC solution for each 50 ml of fetal bovine serum (FBS). 
2.  Mix by inverting and place in a 56°C shaking water bath for 30 minutes.  Invert tubes 
every 5-10 minutes. 
3.  Spin tubes at 3000 rpm for 10 minutes. 
4.  Add 250 µl of DCC to another set of centrifuge tubes. 
5.  Decant FBS into new tubes. 
6.  Mix by inverting and place in a 37°C shaking water bath for 30 minutes.  Invert tubes 
every 5-10 minutes. 
7.  Spin tubes at 3000 rpm for 10 minutes. 
8.  Decant serum into a clean container. 
9.  Filter sterilize into a sterile bottle (0.22 µm filter) 
10.  Aliquot stripped serum and store in freezer. 
 
If FBS has previously been heat inactivated: 
 
1.  Add 9.375 g of charcoal + 0.9375 g dextran to 100 ml of FBS. 
2.  Stir to mix well for 10 minutes. 
3.  Pour into four 50 ml tubes (25 ml each for total of 4 tubes) and spin at 2,000 rpm for 
2 hours. 
4.  Decant serum into clean containers and filter through 500 ml filter (Corning 25943-
500; 0.45 µm cellulose acetate low protein binding membrane. 
5.  Aliquot and store in freezer. 
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APPENDIX G 
PROTOCOL FOR LACTATE DEHYDROGENASE (LDH) ASSAY 
1.  Add 25 ml of tissue culture grade water to lyophilized LDH enzyme. 
2.  Aliquot out enzyme after initial use, do not want to continually freeze and thaw. 
3.  For assay, you want a total volume of 120 µl per well of medium (50% total assay 
mixture and 50% culture medium).  Need equal amounts of LDH assay substrate, 
enzyme and dye solution; therefore, added 20 µl of each for a volume of 60 µl. 
4.  Prepare mixture at time of use and add 120 µl to wells of a 96 well plate, in triplicate. 
5.  Cover plate with foil and put in dark (away from light exposure) for 25 minutes. 
6.  After incubation, add 1/10 volume (18 µl) of 1N HCl to terminate reaction. 
7.  Read plates at 490 nm and then at 690 nm.  Subtract the 690 nm reading from the 490 
nm reading.  Read plates on Packard BS10000 Spectracount microplate reader.  
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APPENDIX H 
PROTOCOL FOR USE OF ZEISS AXIOPLAN 2 MICROSCOPE 
A.  Brightfield and Darkfield image capture 
 1.  Turn general power on.  
 2.  Turn on computer. 
 3.  Turn on microscope and make sure green light on camera is on before 
 proceeding. 
 4.  Open Axiovision, click on “microscope” (top menu), then click on 50:50 for 
 photo and eye view on computer. 
 5.  Set Kohlor Illumination 
  a.  Select objective.  
  b.  Focus on slide with computer (live view and then scope view). 
  c.  Focus each eyepiece individually and then together. 
  d.  Find and close field diaphragm, (right base of scope). 
  e.  Sharpen edges by moving condenser up and down. 
  f.  Center field of diaphragm with little screws under stage. 
  g.  Expand field of diaphragm to be just out of view, may need to sharpen 
  edges again. 
  h.  Close diaphragm above condenser (silver ring above DIC). 
  i.  Remove left eyepiece and adjust diaphragm so you can just see all 
  edges through the scope in the field of view (FOV). 
  j.  Capture images. 
 6.  Turn on camera and click measurement  
 7.  For image capture, use RGB 
  a.  For 10X, use 1300X1030 resolution or 2550X1920 
  b.  For 5X use 2600X resolution 
  c.  For 2.5X use highest resolution 3900X3090 
 8.  Brightfield image capture 
  a.  Use any DIC settings. 
  b.  Can color adjust by clicking “white balance”, then “interactive” button 
  (you must then click on image where you think it is white in color). 
 9.  For Darkfield image capture use “D” settings. 
B.  Cleaning slides for quality images 
 1.  Clean slide surfaces only with cotton swabs and either Windex or 100% 
EtOH.   2.  Do not smear mount medium across coverslip when cleaning surface. 
C.  Saving images 
 1.  To save, click “snap” on camera icon in upper left panel. 
 2.  Can save images as ZVI, TIFF, or JEPG. 
 3.  Save images as 8 bit.  
 4.  At this point, discard color, size, crop, adjust contrast and save images.  
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APPENDIX I 
 
PROTOCOL FOR PRECISION-CUT TISSUE SLICES 
I.  DAY PRIOR TO EXPERIMENT 
 
 1.  Clean the slicer, culture inserts and other glassware required for the  
 procedure.  Prepare the slicing buffer and culture media. 
 
II.  DAY OF THE EXPERIMENT 
 
1. Assemble the slicer.  Make sure that the circular blade is in the correct 
orientation (engraving facing up) and that the size of the tissue core is the 
same as the insert in the slicer.  Begin gassing the slicing buffer (make sure 
that the buffer is circulating through the slicer and that there are no bubbles in 
the slicing chamber or tubing) and running the circulating water bath. 
 
2. Harvest the organ(s) of interest and place in slicing buffer on ice.  Try to 
remove as much blood from the organ by gently 'massaging' the tissue and 
changing buffer. 
 
3. Generate tissue cores by placing the organ on dental wax and carefully 
'rotating' the coring tool through the tissue.  This step is critical -- poor cores 
translate into poor slices.  The tissue cores are placed into slicing buffer (4 
o
C). 
 
4. Place the tissue core into the slicing insert; make sure that core is not sitting 
at an angle. The tissue core will fit firmly in the corresponding insert.  Begin 
rotation of the blade using the power pack - it is critical that the blade is 
rotating clockwise and that the slicing insert is moved over the blade in a 
uniform, precise manner.  The speed which the tissue core is moved across 
the blade depends on both the organ and species used.  Despite the 
availability of a reliable tissue slicer, the production of optimal precision-cut 
tissue slices is also dependent upon the skill and attention of the investigator.   
 
5. The production of optimal, reproducible slices can be evaluated by i) slice 
thickness or ii) slice weight.  It is advantageous to the investigator to 
determine slice thickness during the procedure since the viability of slices is 
highly dependent upon the thickness of the slice.   
 
6. Precision-cut tissue slices are harvested from the slicer into ice-cold slicing 
buffer.  Slices are loaded onto culture inserts (1 to 4 slices per insert).  During 
this step the investigator should handle the slices with care (slices should 
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only be handled with a loading tool - not forceps).   The slices should be 
entirely on the mesh screen and lying flat.  The screens are then blotted and 
placed into the 20 ml scintillation vials containing 1.70 ml of media.  The 
vials are then capped (the caps have a 1 mm hole in them) and placed into the 
Vitron incubator which is gassed with 95:5 O2/CO2 at a flow rate of 1 
ml/min.  The incubator should be cleaned with 70% EtOH before the 
experiment.   
 
 It is important to proceed from sacrificing the animal to organ culture of 
 the slices in an expedient fashion, however do not rush at the expense of 
 generating reproducible, optimal precision-cut tissue slices.   
 
7. Pre-incubate tissue slices for 1 - 2 hr prior to the addition of test compounds.  
This allows the tissue to recover from the slicing process.  Precision-cut 
tissue slices can be cultured for various times, depending on the conditions 
and organ employed.   
 
8. Following the experiment, the slicer and culture inserts are soaked in 
Tergazyme overnight and repeatedly rinsed prior to the next experiment.   
 
BUFFERS 
 
 KREBS-BICARBONATE SLICING BUFFER 
 
 NaCl       27.6 g 
 KCl       1.44 g 
 KH2PO4      0.52 g 
 NaHCO3      8.44 g 
 Glucose      18.0 g 
 CaCl2:2H2O      1.70 g 
 MgSO4:7H2O      1.18 g 
 ddH2O       4 lt 
 
 Add the chemicals in order; before adding the calcium chloride and magnesium 
sulfate dissolve each chemical separately in a small volume of water, then add to 
the buffer.  Refrigerate and bubble with 95:5 O2:CO2 for 30 min before pH to 
7.40, use within 1 week. 
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 SLICING BUFFER 
 
 D-gluconic acid, potassium salt   53.5 g 
 L-ascorbic acid, free acid    8.84 g 
 D-saccharic acid, monopotassium salt  32.7 g 
 L-glutamine      1.40 g 
 Potassium phosphate, monobasic, anhydrous 14.2 g 
 Potassium citrate monohydrate   2.72 g 
 Succinic acid, free acid    0.98 g 
 Magnesium sulfate, heptahydrate   5.15 g 
 Magnesium chloride, hexahydrate   1.70 g 
 Potassium bicarbonate    0.84 g 
 Glucose      1.50 g 
 Fructose      1.50 g 
 Adenosine, free base     5.66 g 
 Glutathione (reduced)     7.75 g 
 Deferoxamine      13.8 mg 
 ddH2O       4 lt 
 
 pH to 7.40 with saturated KOH, use within one week. 
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